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 Preface 
The main task of the Nordic Expert Group for Criteria Documentation of Health 
Risks from Chemicals (NEG) is to produce criteria documents to be used by the 
regulatory authorities as the scientific basis for setting occupational exposure 
limits for chemical substances. 
For each document NEG appoints one or several authors. Evaluation is made of 
all relevant published, peer-reviewed original literature found. The document aims 
at establishing dose-response/dose-effect relationships and defining a critical 
effect. No numerical values for occupational exposure limits are proposed. 
Whereas NEG adopts the document by consensus procedures, thereby granting 
the quality and conclusions, the authors are responsible for the factual content of 
the document.  
The evaluation of the literature and the drafting of this document on Microbial 
volatile organic compounds (MVOCs) were made by Dr. Anne Korpi at the 
University of Kuopio, Finland, Dr. Jill Järnberg at the National Institute for 
Working Life, Sweden, and Prof. Anna-Liisa Pasanen at the Finnish Institute of 
Occupational Health, Finland. The draft document was discussed within the group 
and the final version was accepted by NEG on November 28, 2006. The following 
individuals participated in the elaboration of the document: 
 
Gunnar Johanson Institute of Environmental Medicine, Karolinska Institutet and National 
Institute for Working Life, Sweden (chairman) 
Maria Albin Department of Occupational and Environmental Medicine, University 
Hospital, Lund, Sweden (NEG expert) 
Karin Sørig Hougaard National Institute of Occupational Health, Denmark (NEG expert) 
Kristina Kjærheim Cancer Registry of Norway, Norway (NEG expert) 
Vidir Kristjansson Administration of Occupational Safety and Health, Iceland (former 
NEG expert) 
Kai Savolainen Finnish Institute of Occupational Health, Finland (NEG expert) 
Vidar Skaug National Institute of Occupational Health, Norway (NEG expert) 
Jill Järnberg and  
Anna-Karin Alexandrie 
National Institute for Working Life, Sweden (NEG secretariat) 
 
 
Editorial work and technical editing were performed by the NEG secretariat. 
This work was financially supported by the Swedish National Institute for 
Working Life, the Norwegian Ministry of Labour and Social Inclusion and the 
Nordic Council of Ministers. 
All criteria document produced by the Nordic Expert Group may be down-
loaded from www.nordicexpertgroup.org.  
 
 
Gunnar Johanson, Chairman of NEG
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1. Introduction 
Microbial volatile organic compounds (MVOCs) are produced in the metabolism 
of microorganisms such as fungi and bacteria. They are formed during both the 
primary metabolism (from the synthesis of e.g. DNA and amino and fatty acids) 
and the secondary metabolism (from intermediates of the primary metabolism)  
as side-products, mainly in the metabolic oxidation of glucose from various 
intermediates (23). Thus, the production of MVOCs is greatly affected by micro-
bial species, growth phase and conditions (nutrients, pH, humidity, temperature) 
(19, 125, 216). More than 200 compounds have been regarded as MVOCs in the 
literature. The compounds also have other environmental sources than microbial 
metabolism. Thus, compounds originating solely from microbial metabolism 
hardly exist.  
The interest to utilise MVOCs as indicators of biocontamination was originally 
raised by the food-processing industry in the 1970s, when analysis of unpleasantly 
smelling MVOCs was suggested to be a practical and rapid tool to detect unde-
sirable or spoilage processes caused by microorganisms during the storage or 
processing of foodstuffs (36, 38, 53, 54, 99, 100, 131, 147, 226). Later, MVOC 
analyses and profiles were applied to the taxonomy research to identify and 
separate microbial (mainly fungal) species or strains (71, 95, 103, 126, 127, 222, 
235). MVOCs were analysed in indoor air environments for the first time in the 
1990s (20, 149, 197, 210, 211, 224); with MVOC analysis, a possibility to detect 
hidden microbial growth behind interior surfaces without opening building 
structures was presented. It was assumed that, as gases, MVOCs may enter the 
indoor air (e.g. through water vapour barriers) more easily than spores (135, 197, 
213). The concern about possible health risks related to MVOC exposure in 
indoor environments was also raised in the 1990s. As eye and upper respiratory 
tract irritation was frequently reported by occupants in buildings with moisture 
and mould damage, these symptoms were concluded to be associated with 
exposure to irritative substances of microbial origin (34). Interestingly enough, 
much less attention has been paid to MVOCs and their possible adverse health 
effects in work environments with productive microbial sources or high levels  
of contamination, where occurrence of at least some MVOCs is obviously more 
abundant than in indoor environments. 
This document reviews the literature on compounds most frequently denoted 
MVOCs. From 96 typical MVOCs listed, 15 compounds were chosen for closer 
toxicological evaluation (Tables 2-3); for selection criteria see page 4. The data  
on the individual compounds presented in this document are utterly condensed, 
focusing on inhalation studies and the lowest administered doses, and are largely 
based on toxicological reviews and TOXNET (a collection of toxicology and 
environmental health databases) data. Thus, high dose effects of individual 
compounds are not dealt with, as they are considered irrelevant in the context of 
MVOCs. However, some of the compounds denoted MVOCs are also industrial 
chemicals. As industrial exposure levels are generally much higher than those 
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encountered in the MVOC context also the lowest available doses are high when 
compared with levels of microbial origin. Most of the concern regarding MVOC 
exposure has been raised for home environments. In the present document, focus 
is on the non-industrial working population rather than the general public, although 
the majority of the available data originates from dwellings.  
2. Substance identification  
MVOCs are formed during both the primary and the secondary metabolism as 
side-products, mainly in the metabolic oxidation of glucose, from various pre-
cursors, such as acetate, amino acids, fatty acids, and keto acids (23). The primary 
metabolism of microorganisms comprises the synthesis of DNA and amino and 
fatty acids, whereas the secondary metabolism consists of reactions following the 
primary metabolism. As the primary metabolism involves an interrelated series of 
enzyme-catalysed chemical reactions, it is basically the same for all living systems 
(113). Thus, for several compounds denoted MVOCs also other sources, such as 
vegetation and even mammalian breath, sweat, and skin emanations, have been 
identified (83, 203). The identified MVOCs are alcohols, ketones, terpenes, esters, 
lactones, hydrocarbons, aldehydes, sulphur and nitrogen compounds (93, 126, 
221). The complex metabolic pathways for MVOC formation are depicted in 
Figure 1 and the precursors of some common MVOCs are presented in Table 1. 
For convenience, it is often stated that MVOCs are side-products of the primary 
metabolism of microorganisms, and mycotoxins are end-products of the second-
dary metabolism. However, since the division between primary and secondary 
metabolism is not absolute (21), it can only be stated that MVOCs are formed 
during both (23). As nutritional imbalances and disorders (e.g. a lack of primary 
carbon and nitrogen sources) lead to expression of the secondary metabolism, 
changes in the nutritional state may often promote or trigger the production of 
several MVOCs (23, 27, 113, 205). On the other hand, it has been suggested that 
secondary metabolites may be inhibitors of the primary metabolism (198), and 
volatile metabolites of certain bacteria may stimulate mycotoxin production (18). 
The production of certain fungal MVOCs has also been suggested to be associated 
with mycotoxin production. Evidence of such relationships has been reported 
between the production of sesquiterpenes and aflatoxins, between monoterpenes, 
sesquiterpenes and trichothecenes, and between ketones and ochratoxins (57, 58, 
95, 169, 223, 235).  
Chemical reactions in the environment may further convert the produced 
MVOCs to other compounds. For example, alcohols are easily oxidised to alde-
hydes and further to carboxylic acids (224), and ketones may react with hydroxyl 
radicals in the air to form aldehydes (15).  
Chemical reactions may also produce compounds denoted MVOCs in the 
atmosphere; the reactions between ozone (and other oxidants) and unsaturated 
hydrocarbons (isoprenes/terpenes) have recently been investigated experimentally. 
The main products in these reactions are aldehydes, ketones, and organic acids, 
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but the intermediate products formed during the reactions have been suggested  
to be much more irritating than the corresponding original reactants and end-
products (208, 228, 229). For example, under humid conditions, the reaction 
between ozone and isoprene produces hydrogen peroxide, methacrolein, and 
methylvinyl ketone (179), all of which are known irritants. 3-Methylfuran is 
suspected to be another oxidation product of isoprene (83). 
Finally, it must not be overlooked that the same compounds denoted MVOCs 
may also have other sources in the environment, such as building materials, 
human activities, traffic, foodstuffs, smoking, etc. (83, 183, 198). 
So far, more than 200 individual compounds have been recognised as MVOCs 
in laboratory studies (93, 126, 221). The majority of the experimental studies has 
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Figure 1. Main metabolic pathways for the production of some MVOCs and mycotoxins 
(73, 113, 198, 205, 215). Volatile compounds are in italics.  
Abbreviations: Co A = coenzyme A, PP = pyrophosphate, TCA = tricarboxylic acid 
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Table 1. Some common MVOCs and their precursors in the microbial metabolism. 
 
Precursor Volatile product(s) Reference 
 
Amino acids 
Alanine Acetaldehyde (81) 
α-Amino acids Alkyl methoxy pyrazine (198) 
Glycine Formaldehyde (81) 
Leucine 3-Methyl-1-butanol (23, 27, 191)  
Methionine, cysteine Dimethyl disulphide (27, 198) 
Valine 2-Methyl-1-propanol (23, 27, 191) 
Phenylalanine Phenyl acetaldehyde, styrene (23, 27, 81, 126, 191)  
Organic acids 
Fatty acids Alkenes and alkadienes, aldehydes 
methylketones with one carbon less 
than the original fatty acid (e.g. 2-
butanone, 2-pentanone, 2-hexanone, 
2-heptanone, 2-undecanone) 
(81, 198, 221)  
 
Medium-chain fatty acids Acetates (23)  
γ- or δ-Hydroxy acids, keto 
acids, long-chain fatty acids 
4-Hexanolide, 6-pentyl-α-pyrone (44, 68, 198)  
Linoleic acid, linolenic acid 1-Octen-3-ol, 3-octanol, 3-octanone, 
hexanal, heptanal, nonanal 
(27, 45, 126, 231) 
 
Others 
Isopentenyl pyrophosphate Terpenoid compounds: 
monoterpenes, 
sesquiterpenes and their alcohols, 
geosmin  
(22, 27, 198, 205, 206)  
 
 
 
been carried out with pure cultures of selected, individual microbial species, often 
grown on agar, cereals and other foodstuffs, bedding materials (e.g. straw, peat, 
shavings) or building materials (e.g. wood, wall paper, gypsum, chip-, card- and 
plasterboards, insulation materials like glass and mineral wool), degradable house-
hold waste, and house dust (30, 36, 37, 39, 69, 71, 72, 74, 75, 77, 95, 99, 100, 118, 
123, 145, 146, 169, 182, 186, 187, 198, 200, 201, 211, 215, 220-224, 235, 236, 
238). In a few studies, MVOCs produced by mixed cultures on building materials 
have been investigated (33, 49, 50, 64, 116, 214). In these studies, MVOCs were 
produced by species/strains of microbial genera common in the environment, such 
as Absidia, Acremonium, Alternaria, Aspergillus, Botrytis, Candida, Chetomium, 
Cladosporium, Coniophora, Fusarium, Paecilomyces, Penicillium, Phialophora, 
Poria, Pseudomonas, Rhizopus, Saccharomyces, Serpula, Stachybotrys, Strepto-
myces, Trichoderma, Ulocladium and Wallemia. 
The 15 MVOCs that were selected for closer examination in the present docu-
ment are listed in Table 2 and represent compounds analysed and reported in 
laboratory or field studies. In these studies, the selection of compounds identified 
has often been limited to 10-15 due to study design and analytical restraints, and 
the whole range of MVOCs has not been monitored. For example, acetaldehyde, 
nonanal, 2-pentanone, limonene, and sesquiterpenes are among the most commonly 
identified microbial metabolites in laboratory experiments, still they have not been 
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reported in field samples, probably due to non-microbial sources in the field, and 
analytical limitations (sesquiterpenes). 
A more comprehensive list covering 96 frequently reported MVOCs including 
substance identification data are given in Table 3. For additional lists of com-
pounds, the reader is referred to the publications by Jelen and Wasowics (93) and 
Larsen and Frisvad (126). 
Thus, based on present knowledge, it is difficult to make a reliable list of 
relevant MVOCs. This is due to the fact that in the majority of experimental 
studies, control experiments are missing, as respective sterile materials and their 
qualitative and quantitative emissions have seldom been reported. Therefore,  
the concepts of VOC and MVOC overlap inasmuch as the origin of a compound 
reported as an MVOC may well be the emission of a substrate as well. This 
hampers the interpretation of the data in field settings. For example, Wilkins  
and Larsen (221) have suspected that toluene, xylenes, and ethyl benzene might 
not result from microbial metabolism, even though these compounds are often 
reported as MVOCs. Furthermore, an individual MVOC cannot be related to a 
certain microbial species, because the same MVOC may be produced by different 
microorganisms; e.g. bacterial and fungal species share the same MVOCs. This is 
natural due to the similarities in metabolism as well as growth conditions that are 
one of the key factors for the MVOC production in any microbial species. Finally, 
the methodology used for MVOC analyses varies between studies and affects the 
MVOC profiles reported in the literature considerably. Attempts have been made 
to apply principal component analysis in order to identify areas of microbial 
contamination relying on the VOC profiles of environmental samples (224). 
 
Table 2. Most often reported MVOCs in living environments, and conversion factors (163). 
 
Compound Conversion factors  
(25 °C, 101.3 kPa) 
Reference 
 1 ppm = 1 mg/m3 =  
 
2-Methyl-1-propanol 3.03 mg/m3 0.330 ppm (197) 
3-Methyl-1-butanol  3.61 mg/m3 0.277 ppm (66, 135, 144, 148, 149, 192, 
197) 
3-Methyl-2-butanol 3.61 mg/m3 0.277 ppm (197)  
2-Pentanol 3.61 mg/m3 0.277 ppm (66, 135, 144, 192, 197) 
3-Octanol 5.33 mg/m3 0.188 ppm (40, 66, 192, 197) 
1-Octen-3-ol 5.24 mg/m3 0.191 ppm (40, 66, 135, 144, 149, 164, 
192, 197) 
2-Octen-1-ol 5.24 mg/m3 0.191 ppm (40, 66, 148, 149, 192, 197) 
3-Methylfuran 3.36 mg/m3 0.298 ppm (135, 144, 149, 164, 192, 197) 
2-Hexanone 4.10 mg/m3 0.244 ppm (66, 135, 197) 
2-Heptanone 4.67 mg/m3 0.214 ppm (66, 135, 148, 149, 192, 197) 
3-Octanone 5.24 mg/m3 0.191 ppm (66, 135, 144, 192, 197) 
2-Methylisoborneol 6.88 mg/m3 0.145 ppm (192, 197) 
2-Isopropyl-3-methoxy-pyrazine 6.22 mg/m3 0.161 ppm (192, 197) 
Geosmin 7.46 mg/m3 0.134 ppm (192, 197) 
Dimethyl disulphide 3.85 mg/m3 0.260 ppm (135, 144) 
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3. Physical and chemical properties 
Some physical and chemical properties of MVOCs (from Table 3) are listed in 
Table 4. An indication of the volatility of a compound can be deduced from the 
number of carbon atoms, the molecular weight, boiling point, and the vapour 
pressure (198). The interpretation of vapour pressures of the MVOCs presented in 
Table 4 is as follows: 0.00001-0.001 kPa = moderately volatile, 0.001-0.1 kPA = 
volatile and >0.1 kPa = very volatile compound (159).  
 
Table 4. Some physical and chemical properties of compounds reported as MVOCs. Data 
is partly based on calculated/predicted coefficients (41, 46, 47, 88, 89, 91, 151, 196). 
Substances selected for closer examination are highlighted.  
Octanol:water partition 
coefficient, log Kow 
Compound 
 
Boiling point 
(°C) a at 101.3 
kPa  
Vapour pressure 
(kPa) at 25 °C 
Experimental Calculated 
Alcohols     
1-Butanol 117.7  0.587-0.73 c 0.88  
4-Decanol 210.5  0.0049   3.71 
Ethanol 78.5  5.9 c -0.32  
2-Ethyl-1-hexanol 183.5  0.007 c 
0.048 c 
 2.73 
2-Heptanol 159.2  0.164  2.31  
1-Hexanol 157.1-157.5  0.124  2.03  
2-Methyl-1-propanol 108 1.33  0.65  
0.83 
 
2-Methyl-1-butanol 128 0.416  1.29  
3-Methyl-1-butanol 130.5  0.316  1.16  
3-Methyl-2-butanol 111.5  1.22  1.28  
1-Octanol 194.5-195  0.0106  3.00  
3-Octanol 169.0 0.068   2.73 
1-Octen-3-ol 180 0.071   2.60 
2-Octen-1-ol 195.8 ± 8.0  0.014   2.59 
1-Pentanol 137.8  0.218 c 1.42  
1.48  
1.51 
 
2-Pentanol 119.0-119.3 0.815  1.19   
1-Propanol 97.2- 97.8 1.9 - 2 c 0.25  
0.34 
 
Aldehydes     
Acetaldehyde 20.2 100c -0.34  
Acrolein 52.5 28.5 c  -0.01 
Benzaldehyde 178-179 0.133 d  1.48 
Decanal 208 0.028   3.76 
Formaldehyde -19- (-)19.5 519 
462 
0.35  
Heptanal 152.8  0.469    
Hexanal 131 1.507   1.78 
Nonanal 191 0.049   3.27 
Octanal 163.4  0.28   2.78 
Phenylacetaldehyde 200 0.049    
 16 
Table 4. Cont. 
Octanol:water partition 
coefficient, log Kow 
Compound 
 
Boiling point 
(°C) a at 101.3 
kPa  
Vapour pressure 
(kPa) at 25°C 
Experimental Calculated 
Hydrocarbons  
Benzene 80 12.7 1.18-1.9  
2.13  
2.15 
 
Ethylbenzene 136.2 1.28 3.15  
1-Heptene 94 7.62  3.99 
Toluene  110.6 2.93 c 2.11-2.80  
1-Methyl-4-
methylethyl benzene 
177.10 0.20  4.10 
2-Methyl-1,3-butadiene 34.067  73.33  2.42 
1-Nonene 146.9 0.720  5.15 
1,3-Octadiene 130-131  1.79   
1-Octene 121.2 2.32  4.57 
Styrene 145.2 0.81 2.95  
Xylenes 129-150 b 0.8-0.867 c 3.12-3.20  
Acids     
Acetic acid 117.9 1.52 c  -0.31  
Octanoic acid 237; 239.7 0.133 e 0.63  
Ethers     
Anisole 155.5 0.472  2.11 
1,3-Dimethoxybenzene 217.5 0.026  2.21 
2,5-Dimethylfuran 93.1 ± 9.0  7.61  2.24 
1-Methoxy- 
3-methylbenzene 
177 0.24  2.66 
1-Methoxy- 
3-methylbutane 
90 11.06  1.96 
2-Methylfuran 65 23.48  1.85 
3-Methylfuran 65-66 21.46  1.91 
2,3,5-Trimethylfuran 121-122 1.92   
Esters 
Ethyl acetate  76.5-77.5 9.73 c 0.66 
0.73 
 
Ethyl-2-methyl 
propionate 
110.1 2.88  1.77 
Ethyl propionate 99.1 5.0  1.21  
Methyl acetate 56.9 23.1 c  
21.7 c 
0.18  
3-Methyl-1-butyl 
acetate 
142.5  0.75 2.26  
Methyl-2-methyl-
propionate 
93-95 6.72  1.28 
Propyl acetate 101.6 4.67 1.39 
1.60 
 
Ketones 
Acetone 56.2  24-24.7 c -0.24  
2-Butanone 79.6  10.33 c 0.26  
0.29 
 
Cyclopentanone 130.6  1.52  0.24 
2-Heptanone 150.6; 151.5  0.213 
0.28 
2.03  
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Table 4. Cont. 
Octanol:water partition 
coefficient, log Kow 
Compound Boiling point 
(°C) a at 101.3 
kPa  
Vapour pressure 
(kPa) at 25°C 
Experimental Calculated 
2-Hexanone 126-128  1.47 c  
0.36 c 
1.38  
3-Hydroxy-2-butanone 148 0.256  -0.36 
3-Methyl-2-butanone 93 8.6 c  0.84 
3-Methyl-2-pentanone 117.3-117.5  2.42  1.16 
4-Methyl-3-hexanone 135-138  1.075  1.66 
2-Nonanone 194 0.086  3.14 
2-Octanone 173 0.23  2.37 
3-Octanone 157-162  0.267   2.22 
2-Pentanone 102 3.59 c 0.91  
3-Pentanone 102 4.7 0.99  
2-Undecanone 231.5  0.013  4.09 
Lactones 
γ-Decalactone 266.7 ± 8.0  0.00113   
Terpenoids     
Acoradiene 273.1 ± 15.0  0.0013   6.99 
β-Bisabolene 275.4 ± 15.0  0.0011   7.12 
Cadinene 120 f 5.33 g   6.19 
∆3-Carene 167-170  0.248   4.61 
Camphene 158.5  0.333   4.22 
β-Caryophyllene 268.4 ± 10.0  0.0017   6.30 
β-Chamigrene 273.2 ± 15.0  0.0013   7.02 
α-Curcumene 276.3 ±15.0  0.0011   6.29 
β-Elemene 252.1 ± 15.0  0.0042   7.04 
α-Farnesene 279.6 ± 15.0  0.00090   7.10 
β-Farnesene 272.5 ± 15.0  0.0013   7.17 
Geosmin 252.4 ± 8.0  0.00041   3.57 
α-Gurjunene 263.9 ± 7.0  0.0022   6.18 
Limonene 170 0.280 c  4.57 
Longifolene 250-255  0.0042   5.48 
2-Methylisoborneol 208.7 ± 8.0  0.0065   3.31 
β-Phellandrene 171.5  0.210   4.70 
α-Pinene 155 0.47   4.83 
β-Pinene 166.0 0.32   4.35 
Thujopsene 256.5 ± 7.0  0.0033   6.12 
Trichodiene 256.7 ± 15.0  0.0033    
Sulphur and nitrogen compounds 
Dimethyl disulphide 109.8  3.83  1.77  
Dimethyl trisulphide 183.1 ± 23.0  0.142   1.87 
2-Isopropyl-3-
methoxy-pyrazine 
210.8 ± 30.0  0.036   2.37 
2-Methoxy pyrazine 153.6 ± 0.0  0.56   0.73 
 
a ± indicates that the value was obtained with an extrapolation model providing a range  
b variable depending on isomer composition 
c 20 °C 
d 26 °C 
e 92.3 °C, extremely low at room temperature 
f 9 mm Hg (1.2 kPa) 
g 180 °C 
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4. Occurrence 
As MVOCs are a result of microbial metabolism, factors that control microbial 
growth also influence MVOC production including: 1) microbial species and 
strains (this is the basis for approaches for species identification based on MVOC 
profile); 2) substrates and nutrients (e.g. lack of certain nutrients leads to terpene 
emissions, and presence of certain amino acids in the substrate results in sulphur 
and nitrogen compounds); 3) moisture conditions (water activity, relative humi-
dity, which affects growth and thereby MVOC production); 4) ergosterol content 
of the growth substrate; 5) ambient VOCs in the air or in the growth substrate, and 
6) temperature (27-30, 33, 36-39, 49, 50, 61, 69, 75, 87, 95, 116-118, 123, 127, 
128, 169, 175, 182-184, 195, 200-202, 217, 222, 223, 225, 235). On the other 
hand, sporulation intensity (the concentration of culturable spores) has not been 
shown to affect the MVOC production (37, 38, 222). Contradictory results on the 
influences of some factors (e.g. production of metabolic CO2, oxygen concentration 
and growth phase / age of the colony) on MVOC profiles have also been reported. 
One explanation for this may be defects in sampling techniques and differences in 
study design (117). Though MVOCs mainly originate from fresh and metabolically 
active microbial contamination, certain MVOCs have been suggested to reflect 
emissions from an aged, perhaps even previous, microbial contamination because 
of their high absorption affinity to building materials (214). MVOC levels indoors 
are a balance between production rates, absorption to and desorption from buil-
ding materials and furniture, and ventilation. 
In minor scale, MVOCs were initially analysed in order to detect undesirable or 
spoilage processes during the storage or processing of foodstuffs (36, 38, 53, 54, 
131, 147, 226). More recently, MVOC analysis was applied to recognise indoor 
odour sources and hidden microbial growth behind interior surfaces without 
opening building structures (20, 149, 197, 210, 211, 224), because it was assumed 
that, being gases, MVOCs may enter indoor air through water vapour barriers 
more easily than spores (197, 209). 
As already mentioned, MVOCs possess an unspecific nature in field settings, 
because the same compounds may also originate from other sources, like building 
materials, human metabolism, cleaning, traffic, foodstuffs, smoking, vegetation, 
etc. (83, 171, 183, 198). In reactions between oxidants like ozone and unsaturated 
hydrocarbons (isoprene/terpenes), hydrogen peroxide, methacrolein, and methyl-
vinyl ketone (179), all of which are known irritants, may be formed (208, 228, 
229). 3-Methylfuran is suspected to be another oxidation product of isoprene (83). 
Thus, it is not possible to conclude whether a compound derives from microbial 
metabolism or from the emission of substrates or environmental pollutants. This 
hampers the specificity and interpretation of MVOC analyses and limits the use of 
MVOCs for identifying contaminated areas in a building. For example, terpenes 
are commonly emitted from wood products, but are also reported as MVOCs in 
laboratory studies. Likewise, 2-ethyl-1-hexanol, which has been denoted an 
MVOC, is a degradation product of phthalates in polyvinyl chloride (PVC) 
 19 
floorings under humid and alkaline conditions (76). Korpi et al reported that moist 
building materials, also when not microbiologically contaminated, emitted com-
pounds that, when deriving from microbial metabolism, would be called MVOCs 
(116). Kuske et al suggested that MVOCs evaporating from humid materials 
could actually be used to indicate moisture problems anticipating fungal growth 
(121). In favourable conditions the microbial germination and growth can occur  
in one day (167). Still, the concentrations of MVOCs cannot unequivocally be 
related to mould grade. According to Laussmann et al, the sum of eight MVOCs 
failed to discriminate rooms according to their mould status (130). Schleibinger  
et al concluded similarly that MVOCs could not be used as predictors for mould 
damage in indoor environments (184). In a study of 40 dwellings with and 44 
dwellings without mould damage, the occurrence of 2-methylfuran and 3-methyl-
furan correlated with smoking rather than with mould infestation. Even though 2-
methyl-1-butanol and 1-octen-3-ol were weakly correlated with fungal state, the 
sensitivity and specificity of these compounds were concluded to be too low to 
make them useful indicators (185). 
5. Measurements and analysis of MVOCs 
As there are no standards, consensus, or even recommendations regarding 
sampling and analysis of MVOCs, the methodology presented in the literature 
varies greatly and comparative data on different methods are scantily available. 
MVOCs can be collected from ambient air with active or passive sorbent samp-
ling. Several sorbents or their combinations, like activated charcoal (e.g. Anasorb 
747), graphitised carbon blacks (e.g. Carbotrap C, Carbopack B), silica gels (e.g. 
Porasil C), and polymers (e.g. Tenax TA or GR, Anasorb 727, Chromosorb 102, 
XAD-4) have been used for both sampling techniques in indoor environments (19, 
50, 63, 198, 199). In addition, carbonyl compounds have been collected separately 
with 2,4-dinitrophenylhydrazine (DNPH)-silica Sep-Pak cartridges in some cases 
(116, 186). Tenax TA has been widely used because of favourable properties 
regarding recovery, breakthrough, and precision during sampling/analysis (199). 
On the other hand, activated charcoal enables longer sampling periods and collec-
tion of very volatile MVOCs (197). 
Nowadays, MVOCs from environmental samples are mainly analysed with 
high-resolution gas chromatography (GC) and mass spectrometry (MS) and 
identified according to their mass spectra. Another applicable detector is the flame 
ionisation detector (FID) (19, 50, 116, 198). The sample preparation depends on 
the sorbent used; e.g. for Tenax polymers, the sample is led from the adsorbent to 
the GC column by a thermal desorption cold trap injector (198), whereas for char-
coal sorbents (such as Anasorb) desorption with solvent (e.g. methylene chloride) 
is required before leading the sample into the GC (197). Carbonyl compounds 
collected in DNPH-silica Sep-Pak cartridges are analysed by high-performance 
liquid chromatography after extraction with acetonitrile (50, 116, 186).  
 20 
Recently, a solid-phase microextraction (SPME)/GC-MS technique has been 
applied to analyse MVOCs qualitatively from microbial cultures or contaminated 
building materials (69, 207). In SPME, a short fused silica fibre coated with a 
polymeric organic material (e.g. polyacrylate and polydimethylsiloxane) is used  
as a secondary phase. Nilsson et al (1996) reported comparable results between 
SPME and Tenax adsorption (160). The SPME method has been applied by 
several research teams to qualitatively characterise fungal emissions (57, 58, 69, 
94, 160, 207). 
Attempts have been made to establish evaluation criteria for indoor environ-
ments (135). The principal component analysis is one approach for interpreting 
chromatograms of house dust samples collected from areas with various grade of 
microbial contamination (224). Also the use of an electronic nose to detect fungal 
contamination in indoor environments has recently been reviewed. The electronic 
nose is aimed to recognise the patterns of compounds related to the occurrence of 
fungi. The authors concluded that at present, despite promising implications, the 
low MVOC concentrations and presence of interfering substances restrict the use 
of the electronic nose in indoor settings (121). 
6. Exposure data 
Measurements of MVOCs in field settings have focused on indoor environments, 
especially buildings with water and microbial damage and/or unspecified indoor 
air problems. Published data on MVOC measurements in problem buildings are 
available mainly from Sweden, Germany, and the USA (40, 66, 106, 135, 148, 
149, 192, 197, 210, 212-214, 239). The aim has not been to get exposure data but 
rather to reveal contaminated areas/buildings. The data are, however, far too limi-
ted for the evaluation of global or even local exposure to MVOCs. Also, the lack 
of standardised and validated analytical methods for MVOCs makes comparison 
between studies difficult (106). Even though the number of determined MVOCs 
and the analytical method has been the same in different studies, the sum of 
MVOCs in problem buildings may differ by three orders of magnitude (66, 149, 
197, 213, 239).  
Table 5 summarises the available data regarding concentrations of MVOCs in 
problem and normal buildings or areas and outdoor air. The indoor air concent-
rations have been measured in residences or in non-industrial work sites such  
as schools. In some of these studies (135, 148, 192), the study design and the 
presentation of the data have not allowed a satisfactory differentiation between 
problem and reference buildings or areas. The concentrations of individual 
compounds in problem buildings have varied from a few ng/m3 to 1 mg/m3, and 
the same compounds have also been identified in reference buildings or areas and 
even outdoor air. Generally, the maximum reported levels of individual MVOCs  
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 22  
are 0.1-10 µg/m3 in problem buildings. However, levels of approximately 100 
µg/m3 of 2-heptanone (148) and 270 µg/m3 of 3-methyl-1-butanol (148) and 2-
octen-1-ol (149) have been reported. The highest individual MVOC concentration 
(approximately 900 µg/m3) is reported for 1-octen-3-ol (149).  
When it comes to the use of the sum of certain MVOCs - or total MVOCs, as 
they are sometimes denoted – investigators have included different MVOCs. In 
fact, different research groups have included from 7 to 23 compounds in the sum 
of total MVOCs. The decision on which MVOCs to include has differed signify-
cantly even if the number of compounds was the same. Bearing in mind the great 
variation in the number of compounds, some ranges for total MVOC levels can 
still be indicated. In problem buildings/areas, total MVOCs have been reported to 
be 0.05-84 µg/m3, in reference areas <0.01-30.1 µg/m3, and in outdoor air from 
n.d.-4.6 µg/m3 (66, 84, 106, 135, 149, 164, 197, 210, 213, 214, 239).  
Because of overlapping concentrations of both individual compounds and the 
sum of selected MVOCs in problem and reference buildings, it is difficult to 
recognise problem buildings on the basis of MVOC measurements, or to establish 
reference values for MVOCs, though some suggestions have recently been pre-
sented. Based on the presented data, concentrations ≥ 20 µg/m3 of 2-octen-1-ol,  
≥ 10 µg/m3of 1-octen-3-ol, ≥ 1 µg/m3 of 3-methyl-2-butanol, 2-methyl-1-propanol, 
2-isopropyl-3-methoxypyrazine, and ≥ 0.1 µg/m3 of geosmin and 3-octanol could 
be assumed to indicate an abnormal level (Table 5). According to Lorenz et al 
(135), the detection of main indicators, i.e. 3-methylfuran, 1-octen-3-ol, and/or 
dimethyl disulphide at concentrations above 0.05 µg/m3 would clearly indicate a 
microbial source. In addition, the presence of at least one of the main indicators 
and the sum of 8 MVOCs exceeding 0.6 µg/m3 or 1.0 µg/m3 would be an indica-
tion of a probable or a very probable microbial source, respectively. To avoid 
false positive results, new buildings (< 6 months), rooms with flower pots, waste, 
and pet cages, and interference from smoking, cooking and baking should be 
excluded (135). At present, the concentration limits suggested by Lorenz et al  
are difficult to apply universally, since different research groups are measuring 
different MVOCs. Differences in methods of sampling and analysis add additional 
variability. 
In some studies (66, 212), increased levels of some MVOCs (3-methylfuran, 
3-methyl-1-butanol, dimethyl disulphide, 2-hexanone, 2-heptanone, 1-octen-3-ol, 
and 3-octanone) were detected before remedial actions and moisture and/or 
microbial contamination control measures in buildings. A decrease in the levels 
were observed after the mitigation, though measurements in some cases showed 
contradictory results (66). Again, the selection of compounds (which has never 
been justified in the MVOC literature) and the analysis methods affect the results.  
Only little attention has been paid to MVOCs in work environments with 
productive microbial sources or high levels of contamination (70). MVOCs, like 
3-methyl-1-butanol, 2-methyl-1-butanol, ketones, furans, sulphur compounds, 
geosmin, and terpenes, have been identified in the air of compost facilities (71, 72, 
133, 152, 237). Individual MVOC concentrations have varied from 0.1 to 1 000 
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µg/m3 (152). In a laboratory study, typical VOCs in composts included carbonyl 
derivatives, organosulphur compounds, pyrazines, pyridines, and oxygenated 
monoterpenes. Concentrations of organic sulphur compounds (thioethers, 
disulphides, and trisulphides) in garden waste were concluded to be sufficiently 
high (10-50 mg/m3) to cause irritation and other symptoms of toxicity among 
waste handling personnel (220). Herr et al reported gradually decreasing 
concentrations of 11 MVOCs (in the range from 0.005 µg/m3 to 6 µg/m3) 
measured at different distances (200-550 m) from a large-scale composting site. 
The authors demonstrated an association between concentrations of residential 
bioaerosol pollution including MVOCs (< 200 m from the plant) and complaints 
of airway irritation (85). In a similar study by Muller et al, compost-derived 
MVOCs (especially terpenes) were registered by measurements at distances of up 
to 800 m from the composting facilities. Dispersal of volatile contaminants from 
the composting plant was associated with odour complaints and irritation symp-
toms (153). Lappalainen et al measured MVOCs in a horse stable. The concentr-
ations were ≤0.5 µg/m3 for 2-hexanone, ≤4.6 µg/m3 for 2-heptanone, and ≤1.5 
µg/m3 for 3-octanone. These authors estimated that the concentrations of potential 
MVOCs were only approximately 0.07-0.31 % of the concentrations of total VOCs 
in the horse stable. The emission rates for single VOCs from bedding materials in 
the stable varied between 0.2 and 2 µg/kg/hour, being about ten times higher than 
the corresponding rates in the laboratory experiments (123).  
To conclude, reported individual and total MVOC levels are quite low and 
barely exceed 1 mg/m3 even in fairly contaminated areas. 
7. Toxicokinetics 
The body burden of MVOCs, as of any chemical substance, is influenced by the 
rate of absorption, distribution, biotransformation, and excretion. MVOCs are by 
definition volatile hence the dominating route of exposure is via inhalation. Based 
on experiences with organic solvents, some of which may also be considered as 
MVOCs, it can safely be assumed that the respiratory uptake of MVOCs is in 
general considerable and that the dermal uptake of vapour is not more than a few 
percent of the respiratory uptake. Since MVOCs are small and mostly uncharged 
molecules they easily diffuse across cellular membranes. Hence, they are readily 
transported between alveolar air and blood and between blood and other tissues. 
The distribution of MVOCs in the body depends on their tissue:blood partition 
coefficients. The log octanol:water partition coefficients of MVOCs are listed in 
Table 4. Substances with high octanol:water partition coefficients tend to have 
high tissue:blood and especially fat:blood partition coefficients (172). Examples 
of such substances are long-chained alcohols (e.g. octanol and decanol), hydro-
carbons (e.g. heptene) and ketones (e.g. undecanone), aromatic hydrocarbons and 
terpenoids (Table 3). For example, the high solubility of terpenes in blood and 
other tissues suggest a high respiratory uptake and thus accumulation in adipose 
tissue (65).  
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Aliphatic and aromatic alcohols and carboxylic acids undergo conjugation with 
glucuronic acid in liver, kidney, intestine, skin, brain, and spleen. Glucuronides 
are excreted from the body via urine or bile. Another important conjugation 
reaction for hydroxyl groups (present in aliphatic alcohols) is sulphation, yielding 
conjugates that are excreted mainly in urine. Oxidation-reduction systems prevail 
in the body for the biotransformation of aldehydes, ketones, and alcohols. Alde-
hydes and ketones can be reduced to alcohols by aldehyde/ketone reductases, 
alcohols can be oxidised to aldehydes by alcohol dehydrogenase, and then further 
oxidised to acids by aldehyde dehydrogenase (190). Ketones may also undergo an 
omega-minus 1 oxidation process to form hydroxyketones and be further metabo-
lised to the corresponding diones (16, 17, 218). One example is 2-hexanone, which 
undergoes biotransformation to the neurotoxic γ-diketone 2,5-hexanedione (32).  
The aromatic ether 3-methylfuran is metabolically activated via microsomal 
oxidation, cleaving the furan ring to a highly reactive unsaturated dialdehyde 
(methyl butenedial) that binds covalently to tissue macromolecules (174).  
For sulphur-containing compounds, the oxidation of sulphur or desulphuration 
occurs by the addition of oxygen via cytochrome P450. Alkene epoxidation and 
oxidative N-, O-, or S-dealkylation proceed via cytochrome P450-mediated 
reactions to form epoxide and hydroxyalkyl moieties, respectively. The formed 
aliphatic epoxides are then hydrolysed to dihydrodiol products, and the hydroxy-
alkyl part decomposes into an aldehyde or ketone and a metabolite containing a 
free amino, hydroxyl, or sulphhydryl group (190).  
8. Biological monitoring 
Methods for biological exposure monitoring are available for many organic 
solvents that also appear as MVOCs, such as acetone, benzene, 1-butanol, 
2-butanone, ethylbenzene, 2-hexanone, toluene, terpenes and xylenes or their 
metabolites (3, 60). However, these methods have been developed and are 
applicable for much higher exposure levels than those typically encountered in  
the MVOC setting. For the 15 MVOCs listed in Table 2, no such methods are 
routinely available. Moreover, although background levels in human blood or 
breath are found for only a few of the typical MVOCs in the scientific literature, 
e.g. acetone, ethanol, isoprene, and methanol (62, 193), most MVOCs are likely  
to be present in small amounts in human tissues, as a result of endogenous or 
microbial metabolism, or both. Thus, a number of the alcohols, aldehydes, ethers, 
and esters listed in Tables 3-4 have been detected in exhaled breath of humans 
(141). The endogenous production and the resulting background levels for these 
compounds are not known exactly, although some VOC measurements have been 
performed from the exhaled breath of humans (67, 171). Obviously, endogenous 
background exposure may invalidate biomonitoring of MVOC at low exposure 
levels. High metabolism rates and low exposure levels restrict the application of 
biomonitoring for the exposure assessment of MVOCs. In addition, two or more 
exposing agents may produce the same metabolites, as it is with 2-hexanone and 
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n-hexane, thus hampering the selection of a specific biomarker for exposure to 
2-hexanone.  
9. Mechanism of toxicity 
MVOCs can elicit a variety of toxic systemic effects at concentrations far higher 
than relevant in this context. Such toxicity is not discussed in this chapter. 
However, sensory irritation is a known effect of exposure to MVOCs. 
Irritation of the eyes and upper airways, i.e. sensory irritation (also called 
pungent sensation), is due to stimulation of the trigeminal nerve (52). It has been 
suggested that the strength of the response depends on the number of occupied 
receptors. Such receptors have though not yet been identified, but several in-
vestigators have suggested their existence (157, 230). It has also been proposed 
that the magnitude of the responses in turn depends on the chemical structure of 
the compounds (157). Even small differences in the chemical structure, such as 
different enantiomers of the same compounds, may affect the potency (104, 158).  
Wolkoff et al (230) have recently proposed that it is possible to distinguish 
between four types of different organic compounds in the indoor environment that 
could provoke sensory irritation in the airways. The groups of the proposed com-
pounds are as follows: 1) chemically non-reactive, stable organic compounds, i.e. 
octane, toluene, butanol and alike; 2) chemically reactive organic compounds like 
alkenes that react with ozone alone or with nitrogen dioxide in the presence of 
light to produce new oxygenated products; 3) organic compounds that form 
chemical bonds to receptor sites in the mucous membranes; 4) organic compounds 
with (known) toxic properties; the latter compounds are characterised by effects 
developed over long duration of exposure. Receptors, if any, that mediate the 
effects of MVOCs remain to be elucidated and characterised. However, it is most 
likely that at least some of the MVOC-mediated effects are due to activation of 
receptors in the airways (5). 
It has been proposed that sensory irritation receptors can be activated in diffe-
rent ways. Physical binding to the receptor is typical for non-reactive VOCs 
including most MVOCs. Chemicals with high water solubility and high reactivity, 
such as ammonia, formaldehyde and acrolein would lead to receptor activation 
through modification of the receptor structure or adjacent structures important for 
receptor activation (5). Other mechanisms that activate receptors associated with 
sensory irritation include chemical reactions of amines and nucleophilic addition 
of isocyanates (8). 
It has also been suggested that irritation may arise through activation of poly-
morphonuclear neutrophils (PMNs), alveolar macrophages or other professional 
phagocytes in the lung tissue (5, 156, 230). These effects are thought to be due to 
proinflammatory and other bioactive mediators released from the phagocytic cells 
upon their activation (158). It should be noted that irritation due to an inflamma-
tory reaction and due to stimulation of nerve endings are not related. Finally, 
pulmonary irritation may appear due to stimulation of vagal nerve endings at the 
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alveolar level. Direct compound-stimulation of vagal nerve endings occurs rapidly 
in relation to the onset of exposure, and disappears when exposure is terminated. 
However, these nerve endings can also be stimulated due to oedema. As oedema 
develops and dissipates slowly, the onset of such an irritative process is slow. 
10. Effects in animals and in vitro studies 
10.1 Irritation and sensitisation 
The most apparent effect following acute MVOC exposure is irritation. In this 
document only irritation from vapours was considered. Skin irritation studies  
with application of concentrated solutions of the test substance were regarded 
irrelevant in the context of MVOCs. 
Alarie (1966) introduced the so-called mouse bioassay, which was later 
established as a standard test method for estimating sensory irritancy of airborne 
chemicals by the American Society for Testing of Materials (ASTM) (14). This 
method has been widely used to assess the sensory irritation potency of aerosols, 
gases, and vapours. Thus, the method is also applicable for estimation of airway 
irritation due to inhalation of MVOCs. In this model, four mice are simultaneously 
exposed head-only to the exposure agent, and their respiratory function is conti-
nuously monitored. When a compound stimulates the trigeminal nerve endings in 
the nasal mucosa, time of breaking (i.e. when inhalation goes into exhalation) 
increases, and the respiratory rate of the animals decreases in a dose-dependent 
manner. The sensory irritation potency can be quantified by the changes in 
breathing patterns and respiratory functions at a given exposure level (airborne 
concentrations of a chemical used in the experiments). From these relationships, 
the concentration causing a 50 % decrease in the respiratory rate (RD50) can be 
estimated (4, 5).  
Schaper (1993) compiled a large database of results obtained by this bioassay. 
In addition to the bioassay, the sensory irritation potencies of non-reactive volatile 
compounds, such as alkylbenzenes, saturated alcohols, and ketones, can be esti-
mated on the basis of physicochemical descriptors (e.g. molecular weight, vapour 
pressure or Ostwald gas-liquid partition coefficient). This is possible because  
the effect of the compounds are probably induced via physical adsorption to the 
biological receptors (1, 6-8). Since most MVOCs are non-reactive (towards SH or 
OH groups in proteins), their RD50s can be calculated theoretically by means of 
the physicochemical variables. RD50s calculated or determined by the mouse 
bioassay for some MVOCs are presented in Table 6.  
In the case of exposure to MVOCs, low exposure concentrations of several 
MVOCs frequently occur (in the range of ng/m3 - µg/m3). Effects of exposure to 
chemical mixtures can be additive, antagonistic, or synergistic. If we assume that 
additivity prevails at low exposure levels to VOC mixtures, the total sensory irri-
tation potency would be the sum of the effects that each compound would elicit  
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Table 6. The RD50 values for some MVOCs (114, 168, 180).  
 
 RD50 Compound 
 mg/m3  ppm 
 
2-Methyl-1-propanol 5 499 1 815 
3-Methyl-1-butanol 9 325 2 583 
3-Methyl-2-butanol 9 645 2 672 
2-Pentanol 9 907 2 744 
3-Octanol 1 359 255 
1-Octen-3-ol  182 35 
2-Octen-1-ol a - - 
3-Methylfuran a - - 
2-Hexanone 10 449 2 550 
2-Heptanone 4 163 891 
3-Octanone 17 586 3 359 
2-Methylisoborneol 811 118 
2-Isopropyl-3-methoxy-pyrazine a - - 
Geosmin 216 29 
Dimethyl disulphide b 37 330 9 700 
 
a  fundamental understanding or data about the substance’s potency as a sensory irritant is missing  
b estimated by document authors by using the formula: 
 log RD50 (ppm) = 2.693 + (0.887·log Po) (Po, mmHg) (8)  
 
alone (156). The estimation is based on the sum of ratios of the fractional 
concentration (c) and the RD50 of each compound:  
1/RD50mixture = ∑ (cn/ RD50n) 
It has been proposed that effects at higher exposure concentrations might show 
synergistic interactions (156). This was verified by Korpi et al who investigated 
the sensory irritation potency of 1-octen-3-ol, 3-octanol and 3-octanone, separately, 
and the potency of the MVOC mixture including 2-methyl-1-propanol, 3-methyl-
1-butanol, 1-octen-3-ol, 2-heptanone and 3-octanone by the mouse bioassay. The 
RD50s for these MVOCs are presented in Table 6. The RD50 for the mixture was 
3.6 times lower than estimated from the sum of fractional concentrations and the 
RD50s of individual compounds (the estimated RD50 was 504 mg/m3 and the 
observed RD50 142 mg/m3). As expected, if a particular compound in the mixture 
is much more potent than the other ones, it may dominate the effect (114). 
Korpi et al also investigated the effect of repeated exposures (30 minutes per 
day during four consecutive days) to 3-octanone (3 531 mg/m3), 1-octen-3-ol (36 
mg/m3), or to a mixture of 2-methyl-1-propanol (~6 mg/m3), 3-methyl-1-butanol 
(~6 mg/m3), 1-octen-3-ol (~19 mg/m3), 2-heptanone (~19 mg/m3) and 3-octanone 
(~6 mg/m3) by the mouse bioassay. The levels for individual MVOC experiments 
were chosen to produce a clear respiratory rate decrease (from 11-20 % for 1-
octen-3-ol with a very steep dose-response curve to 32 % for 3-octanone). The 
proportions of the MVOCs in the mixture were chosen to reflect those measured 
in mouldy buildings or mouldy building materials, and test concentrations were 
chosen to maximally yield a 32 % decrease in the respiratory frequency. For 
single MVOCs, no changes in the responses were observed between the exposures, 
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and only a very slight adaptation in respiratory function occurred along with the 
exposures to the MVOC mixture. The authors concluded that MVOCs seem to act 
as “pure” sensory irritants and the effects of a short-term, repeated exposure seem 
non-cumulative and transient (115).  
Histamine induces inflammation, and in an in vitro study by Larsen et al human 
bronchoalveolar lavage cells were incubated with MVOCs of Trichoderma viride 
(e.g. 2-methyl-1-propanol, 3-methyl-1-butanol, 2-methyl-1-butanol, 1-pentanol) 
with the result of evoked histamine release from the cells. The histamine release 
was stastistically significant when it increased from approximately 12 to 20 % at 
VOC concentrations ranging from 0.04 to 10 % (v/v) (124). Hypothetically, 
exposure to MVOCs, especially to reactive oxygen metabolites (after reactions 
with ozone and other oxidants) may then function as adjuvants by inducing non-
specific airway hyperresponsiveness and inflammation (156). 
In the reactions between oxidants and unsaturated hydrocarbons intermediates 
formed may be much more irritating than the original reactants and end-products 
(179, 208, 228, 229). 
In summary, irritation is the most probable effect of MVOC exposure and 
RD50s for a number of MVOCs have been estimated by the mouse bioassay. 
Assuming additivity at low exposure concentrations the total sensory potency of 
an MVOC mixture can be calculated. However, at higher concentrations synergy 
may occur. Effects of short-term, repeated exposures at levels high enough to 
produce a clear respiratory rate decrease seem to be non-cumulative and transient. 
10.2 Effects of single exposure 
The most apparent effect following acute MVOC exposure is irritation (Chapter 
10.1). However, acute high-level vapour exposure to compounds denoted MVOCs 
generally has the potential to cause narcosis, central nervous system disturbance 
and death (11).  
The lethal dose for 50 % of the exposed animals at single administration (LD50) 
and the corresponding lethal concentration for 50 % of the animals at single 
inhalation exposure (LC50) are measures of the general acute toxic potency of a 
chemical (11) for comparison with other substances. In Table 7, LC50-values, 
lowest observed lethal concentrations (LCLo), and dermal LD50s are presented for 
some of the 15 selected MVOCs. However, for several of those MVOCs such 
values have not been determined. According to the Hodge and Sterner scale the 
substances listed in Table 7, with the possible exception of dimethyl disulphide, 
would be classified as slightly toxic, i.e. having an LC50 in the range 1 000-10 000 
ppm in rats (42). Also the dermal LD50s indicate a low acute toxicity termed as 
slightly (350-2 810 mg/kg) or practically non-toxic (2 820-22 590 mg/kg) 
according to the same toxicity scale. The concentrations of MVOCs need to be 
thousands of mg/m3 (Table 7) in order to produce lethal effects in animals, 
whereas the concentrations of individual MVOCs indoors in general are in the 
range of hundred ng to <1 mg/m3 (Table 5). 
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Table 7. LC50s, LCLos and LD50s for some MVOCs most often reported in field studies.  
 
Compound/  LC50 a  LCLob  Dermal LD50c Reference 
Concentration Duration  Concentration Duration   Species 
mg/m3 ppm h mg/m3 ppm h   mg/kg  
        
2-Methyl-1-propanol        
Rat  19 200-  
24 200 
6 300- 
8 000  
4 24 200 
8 000 
8 000 
2 600 
4 
4 
(88, 162, 176) 
Guinea pig 19 900 6 600  4     (88, 176) 
Mouse 15 500 5 100  2     (88, 176) 
Rabbit 26 200 
2 600 
 
8 600 
860  
- 
4 
    (88, 176) 
Rabbit, male       >2 000 (24) 
Rabbit, female       2 460  
(1 790-3 390) 
(24) 
Rabbit       3 400  (24) 
Rabbit, 
occlusive 
      4 240  
(2 520-7 120) 
(24) 
3-Methyl-1-butanol        
Rabbit       3 240 (2) 
3-Octanol         
Rabbit       >5 000 (25) 
1-Octen-3-ol         
Rabbit       3 300 (26) 
3-Methylfuran         
Mouse 3 000 900 1     (78) 
Rat 6 700 2 000 1     (79) 
Hamster  >26 400 >7 900 1     (79) 
2-Hexanone          
Rat 32 700 8 000 4    (161, 162, 176) 
Guinea pig   82 000 
40 000 
20 000 
9 800 
1.2 
0.5 
 (162, 176) 
Rabbit       4 800 (31) 
2-Heptanone         
Rat    18 600 4 000 4  (176) 
Guinea pig    22 400 4 800 4  (176) 
Rabbit       13 000 (218) 
3-Octanone         
Rabbit, 
occlusive 
      >5 000 (188) 
Dimethyl disulphide        
Rat 15.8d 4.1 d 2     (47, 176) 
Mouse 12.3d 3.2 d 2     (47, 176) 
Rat 3 100 800 4     (47) 
Rat 4 800 1 200 4     (47) 
Rabbit       >2 000 (13) 
 
a = lethal concentration for 50 % of the animals at single exposure 
b = lowest observed lethal concentration 
c = lethal doses for 50 % of the animals at single administration 
d = the validity of the value has been questioned (47)  
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The cytotoxicity of 13 so called MVOCs including e.g. 1-octen-3-ol, 3-octanol, 
3-methyl-1-butanol, 2-methyl-1-propanol, 3-octanone, 2-heptanone and 2-hexa-
none was studied using a human lung carcinoma epithelial cell line A549 in a 
colony formation assay and 2 colorimetric assays. 1-Octen-3-ol and 3-octanol 
were approximately 10-100 times more cytotoxic than the other MVOCs. How-
ever, all tested MVOCs were more than 1 000-fold less toxic than the known 
cytotoxic substance gliotoxin measured as the concentration resulting in 50 % 
inhibition of colony growth or absorbance (120). 
Other toxicological data of relevance on the 15 selected substances are 
presented below:  
2-Methyl-1-propanol: Signs of toxicity reported in acute inhalation studies 
(> 19 000 mg/m3) in several species include narcosis, irritant effects on the 
mucous membranes, and effects on the liver and kidneys (24).  
3-Methylfuran: Acute inhalation studies of 3-methylfuran have revealed 
damage to the epithelium lining the small airways at high doses. Mice appear  
to be more sensitive than rats and hamsters with extensive necrosis of the 
bronchiolar epithelium within one day following a 1-hour exposure to initial 
concentrations of 343-906 ppm (1 149-3 038 mg/m3). Virtually complete 
regeneration of the epithelium was observed within 21 days. 3-Methylfuran-
induced injury occurred also in the liver, lymphoid system, and nasal mucosa 
although species differences were present (78, 79, 150).  
 
Conclusion 
Single exposure data are lacking or are very scarce for all of the 15 selected 
substances. Available data on the alcohols, ketones and 3-methylfuran suggest  
a slight, and those on dimethyl disulphide a slight to moderate acute toxicity. 
Reported effect levels are more than three orders of magnitude higher than 
reported MVOC indoor air levels. 
10.3 Effects of short-term and long-term exposure 
Repeated exposure data, available for 7 of the 15 selected MVOCs, are presented 
below. Focus is on inhalation and the lowest administered doses. If inhalation data 
are lacking or scarce, however, oral data have been included.  
3-Methyl-1-butanol: No compound-related, toxicologically relevant effects 
were found in rats exposed in drinking water to doses up to 1 068 (males) or 1 431 
(females) mg/kg body weight for 90 days (82). Oral exposure of rats to doses up 
to 1 000 mg/kg body weight/day, 7 days/week for 17 weeks, was not accompanied 
by adverse effects. However, a decreased body weight gain, which was ascribed a 
reduced food intake was reported at the highest dose (82). 
2-Methyl-1-propanol: A comprehensive set of neurotoxicity tests including an 
assessment of complex behaviour dependent on learning and memory, full 
histopathology and blood chemistry evaluations were conducted following the 
exposure of rats to 0, 250, 1 000, and 2 500 ppm (0, 760, 3 030, and 7 600 mg/m3) 
for 90 days. A slight decrease in response to external stimuli was observed during 
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the actual exposures at all concentrations. There were no morphological or 
behavioural effects indicative of a specific, persistent or progressive effect on  
the nervous system at any exposure level (132).  
In two 90-day studies in male and female rats and according to OECD guide-
lines, no-effect-levels of approximately 316 and 1 450 mg/kg body weight/day 
were determined following administration by gavage and in drinking water, 
respectively (24, 181).  
3-Octanol: In a recent subchronic oral toxicity study, no effects were observed 
in rats dosed with 25 mg/kg body weight. Treatment-related lesions in the kidney 
(100 mg/kg body weight) and liver (400 mg/kg body weight) were observed at 
higher dose-levels (134). 
3-Methylfuran: In male and female hamsters and mice exposed for a total of 2 
hours to an initial concentration of 8 400 ppm (28 200 mg/m3) and a final ditto of 
1 900 ppm (6 400 mg/m3), and for 1 hour to an initial concentration of 700 ppm 
and a final concentration of 400 ppm (2 400 and 1 300 mg/m3), respectively, once 
a week for 10 consecutive weeks, the result of respiratory function tests and the 
histopathologic evaluation of the lungs did not reveal any major long-lasting 
changes 10 months later. In mice, the tumour incidence in exposed animals was 
not increased when compared to controls 2 years after exposure (227). 
2-Hexanone: The target tissue in 2-hexanone toxicity is the nervous system. 
Neurotoxic effects, expressed as peripheral neuropathy, and weight loss/retarded 
weight gain, have been observed in several species after repeated exposures and 
different modes of administration (31, 32, 138).  
Exposure to 40 ppm (164 mg/m3) of 2-hexanone vapour 8 hours/day, 5 days/ 
week for 22-88 days did not result in any clinical or pathological signs of neuro-
pathy in rats, whereas 3/20 rats showed demyelination of the sciatic nerve after  
13 weeks of exposure to 50 ppm (205 mg/m3) of 2-hexanone vapour under similar 
conditions (LOEL). In rats exposed for 6 months a reduced nerve conduction 
velocity was observed within 17 weeks. Even after 6 months of exposure no 
clinical signs of neuropathy were observed, but wide-spread demyelination of  
the sciatic nerve was seen in 32/40 rats. It cannot be ruled out that prolongation  
of the 40 ppm exposure would have revealed signs of neuropathy at a later time. 
In another study, exposure to 100 ppm (410 mg/m3) of 2-hexanone vapour for  
6 hours/day, 5 days/week resulted in a reduced motor conduction velocity of the 
sciatic-tibial nerve in male rats within 29 weeks (n=30) as well as in male 
monkeys (within 9 months) (n=24). Complete recovery occurred in monkeys 
within 2 months post-exposure. 
Rats exposed to 200 ppm (820 mg/m3) of 2-hexanone vapours for 6 weeks (8 
hours/day, 5 days/week) showed several signs of neuropathy (axonal hypertrophy 
and segmental breakdown of myelin). Continuous inhalatory exposure of 12 rats 
to 225 ppm (920 mg/m3) resulted in clinical paralysis after 66 days.  
Chicken continuously exposed to 100 ppm (410 mg/m3) 2-hexanone vapour 
developed hind limb dragging after 4-5 weeks.  
 32  
The neurotoxicity of 2-hexanone is enhanced by co-exposure to other chemi-
cals, especially other ketones like 2-butanone. 2-Hexanone can also potentiate the 
toxicity of other compounds, such as chloroform and carbon tetrachloride (31, 32, 
138).  
2-Heptanone: Repeated (n=19) inhalation exposures of 115-1 500 ppm (540-
7 000 mg/m3) for 6-8 hours did not cause behavioural changes in rats, but some 
reduction in response rate occurred at exposure to 1 575-1 900 ppm (7 400-8 900 
mg/m3). Tolerance developed over the course of the study (12).  
No adverse effects on cardiopulmonary function, clinical chemistry, or signs of 
neurotoxicity were noted in male rats and monkeys after inhalation exposures up 
to approximately 1 000 ppm (4 700 mg/m3) for 9-10 months, 6 hours/day, 5 days/ 
week (97, 98, 140). 2-Heptanone has been shown to increase the chloroform 
induced nephro- and hepatotoxicity in rats (86). 
Dimethyl disulphide: No toxic effects were noted in rats after inhalation of  
100 ppm (390 mg/m3), 6 hours/day for 20 days (137). 
Two other inhalation studies of rats exposed to dimethyl disulphide 6 hours/ 
day, 5 days/week for 13 weeks, and according to OECD guidelines, have been 
performed. In the first study, reduced body weight and food intake, and changes in 
some serum biochemical parameters were observed at 25 ppm (96 mg/m3) in the 
males. At 125 ppm (480 mg/m3) the same effects and in addition an increase in 
some organ weights were seen in both genders. No treatment-related effects were 
observed at the lowest exposure level of 5 ppm (19 mg/m3) (108). In the other 
study, hypoactivity, reduced body weight and food consumption, and changes in 
organ weights and in white blood cell counts were reported. Reversible micro-
scopic changes in the nasal mucosa were noted at all exposure levels (10, 50, 150 
and 250 ppm) (38, 190, 580 and 960 mg/m3). The NOEL was judged to be slightly 
lower than 10 ppm (13). 
Conclusion 
The animal short- and long-term toxicity database is poor for most of the 15 
selected substances. For some of the alcohols, and for 2-heptanone, the available 
data indicate a slight toxicity. Two 13-week inhalation studies on dimethyl 
disulphide in rats suggest a NOEL below 10 ppm (38 mg/m3). In rats, peripheral 
neuropathy has been observed after exposure to 50 ppm (205 mg/m3) 2-hexanone 
(LOEL). Thus, adverse effects from some of the selected substances have been 
reported only at doses far higher than what can be obtained when their main 
source is microbial.  
10.4 Mutagenicity and genotoxicity  
Genotoxicity tests on the 15 substances selected for further investigation are 
summarised in Table 8. With few exceptions results are negative. Data are lacking 
for some of the substances.  
As examples of recent studies on MVOCs, Kreja and Seidel (119) investigated 
genotoxic, clastogenic, and mutagenic potential of 16 MVOCs in vitro (Table 8). 
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Each compound induced DNA damage only under cytotoxic conditions. 
Clastogenic (causing chromosomal breaks) and mutagenic effects were not 
detected.  
In contrast, SOSa-inducing activity was reported for 15 out of 20 MVOCs 
including 2-methyl-1-propanol, 3-methyl-1-butanol, 3-methyl-2-butanol, 2-
pentanol, 3-octanol, 1-octen-3-ol, 2-hexanone, 2-heptanone, and 3-octanone in  
the luminescent umu test. 3-Methyl-2-butanone and 3-methyl-2-butanol were the 
only MVOCs that were tested positive also in the less sensitive conventional light 
absorption umu test. These two MVOCs were subsequently tested also in the 
Ames test and were reported positive (154).  
10.5 Carcinogenicity 
The International Agency for Research on Cancer (IARC) has not evaluated the 
carcinogenicity of any of the 15 MVOCs listed in Table 2. The United States 
National Toxicology Program (NTP) has not listed those chemicals in its report  
on carcinogens (165). In the broader list of identified MVOCs (Table 3), some 
substances (such as formaldehyde) are classified as human carcinogens or as 
possible human carcinogens (such as acetaldehyde, ethylbenzene, isoprene, and 
styrene). Considering the low concentrations encountered in the MVOC context, 
cancer is not likely to be a concern. The very few studies that were retrieved from 
the literature are described below.  
3-Methyl-1-butanol: Oral administration of approximately 81 mg/kg body 
weight, twice a week for 135 weeks, or subcutaneous injection of approximately 
32 mg/kg body weight, once a week, for 95 weeks, induced an increase in the 
incidence of malignant tumours in rats (4 and 10, respectively). No malignant 
tumours were found in the controls (82). The study design and documentation of 
reported findings have several flaws, which hampers the interpretation of the data, 
e.g. a low number of animals, unknown sex ratios, lack of information on tumour 
incidences in historical controls, and the exceeding of the maximum tolerated 
dose evidenced by chronic toxic effects on the liver and haematopoietic system. 
2-Methyl-1-propanol: In rats, oral administration of approximately 160 mg/kg 
body weight, twice a week for 72 weeks, or subcutaneous injection of approxi-
mately 41 mg/kg body weight, twice a week, for 90 weeks led to an increase in 
the number of malignant tumours. No malignant tumours were seen in the controls 
(24). The study does not comply with current standards (see text on 3-methyl-1-
butanol). 
 
 
 
 
 
 
a The SOS response in bacteria describes changes in gene expression in response to DNA damage. 
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10.6 Reproductive and developmental studies 
Studies on reproductive and developmental effects of MVOC exposure are rare. 
Of the selected 15 MVOCs, data exist for 4 compounds. 
3-Methyl-1-butanol was tested for developmental toxicity in pregnant Wistar 
rats and Himalayan rabbits. Twenty-five female rats and 15 female rabbits per 
group were exposed to 3-methyl-1-butanol vapour at concentrations of 510, 2 500, 
or 9 800 mg/m3, 6 hours/day. The rats were exposed on days 6-15 postcoitum and 
the rabbits were exposed on days 7-19 after insemination. The dams were sacrificed 
on day 20 respectively day 29. The foetuses were removed from the uterus and 
examined for malformations and variations externally, in soft, and in skeletal 
tissue. Exposure to 9 800 mg/m3 caused eye irritation in dams of either species 
during the exposure. Pregnancy and litter data were similar in all groups, and no 
signs of embryo- or foetotoxicity were observed in foetuses of either species. The 
overall incidence of variations was significantly increased in rabbit offspring in 
the highest exposure group, however the number of malformations exhibited no 
differences between groups (109). 
2-Methyl-1-propanol was tested for developmental toxicity in a study of similar 
design as described above for 3-methyl-1-butanol, with exposure concentrations 
of 510, 2 500, or 9 800 mg/m3. Pregnancy and litter data were similar in all 
groups, and no signs of embryo- or foetotoxicity were observed in foetuses of 
either species. The overall incidence of variations was significantly increased in 
rabbit offspring in the highest exposure group, whereas the number of foetuses 
with retarded ossification was lowest in this group. The number of malformations 
exhibited no differences between groups (109). 
2-Hexanone: Male rats (strain not specified) were exposed to 700 ppm (2 870 
mg/m3) 2-hexanone for 72 hours weekly (two 20-hour and two 16-hour exposure 
periods) for 11 weeks. Exposure was associated with a marked reduction in body 
weight. Generally, organ weight changes reflected the reduction in body weight, 
however both absolute and relative weight of testes were significantly reduced. 
Microscopically, atrophy of the testicular germinal epithelium was observed 
(105). 
Peters et al exposed groups of 25 pregnant Fisher 344 rats by inhalation to  
0, 500, 1 000, or 2 000 ppm (2 050, 4 100 or 8 200 mg/m3) 2-hexanone for 6 
hours/day throughout gestation. Five male and female pups per group (one from a 
litter) were examined for developmental landmarks and tested for simple reflexes, 
activity in open field and running wheel, food maze behaviour, a swimming stress 
test, and shock avoidance. Tests were performed at puberty, adulthood, and old 
age, however all exposure groups were not tested in all tests at all ages. Additional 
animals were tested for pentobarbital-induced sleeping time, clinical chemistry, 
and haematology. Offspring from the 500 ppm group had to be discarded due to 
non-treatment related circumstances. Maternal weight gain was non-significantly 
reduced at the two higher concentrations, and a detectable change in neurological 
function was observed in 2 000 ppm dams. These females produced smaller litters 
of lower weight pups, the latter persisting in male offspring throughout life. 
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Behavioural alterations were detected in most tests. In the food maze, offspring 
from exposed animals performed better at puberty but poorer as adults. Treated 
offspring exhibited reduced activity in the open field early in life (2 000 ppm)  
and increased activity in the running wheel up until adulthood. Performance in 
avoidance conditioning was poorer in puberty females, and the treated animals 
generally exhibited increased random movement during the intertrial interval 
(1 000 ppm). A few sporadic changes were also noted in clinical chemistry values, 
however consistency lacked. Haematology revealed no differences between 
exposed and control groups (170).  
Dimethyl disulphide: Rats were exposed to 0, 5, 15 and 50 ppm (0, 19, 58 and 
190 mg/m3) dimethyl disulphide for 6 hours/day from day 6 to day 15 of gestation. 
Exposure to 50 ppm caused marked maternal toxicity and foetal growth retardation. 
At 15 ppm, there were less marked maternal toxicity and no foetal effects. No 
maternal or foetal effects were observed at 5 ppm (13). 
Smotherman and Robinson examined the behavioural responses of near term rat 
foetuses to a range of potential chemosensory fluids, including milk and dimethyl 
disulphide, a constituent of pup saliva promoting postnatal nipple attachment. 
Only milk and dimethyl disulphide altered foetal motor activity and foetal res-
ponsiveness to perioral cutaneous stimulation, suggesting dimethyl disulphide  
acts as a chemical messenger during the neonatal period. Furthermore, the opiod 
antagonist naloxone reversed the pup behavioural response to dimethyl disulphide, 
indicating that this chemical is capable of promoting opiod activity, as is milk 
(194). 
 
Conclusion  
Studies are lacking for most of the 15 selected substances. Some effects on 
postnatal development and behaviour have been reported after 2-hexanone 
exposure of pregnant rats. However, considering the low levels encountered in 
MVOC settings reproductive and developmental effects caused by MVOCs are 
unlikely.  
11. Observations in man 
11.1 Odour sensation, irritation and sensitisation 
Complaints of unpleasant odours are often presented in damp buildings with 
microbial contamination (173, 192, 197). Because many MVOCs have musty, 
earthy, mushroom-like, sweet, and/or fruity smell, MVOCs have been assumed to 
be responsible for odour sensations in problem buildings (106, 178). However, the 
occurrence of MVOCs or odours is not a direct measure of the extent of microbial 
growth in a building (96, 197) because many factors affect MVOC levels indoors 
as well as the human sensation of odours (the odour threshold of an MVOC, 
occupants’ susceptibility to odour). The odour thresholds may vary at least by a 
factor of 108 (from 10-7 to 101 ppm) between individual MVOCs and by a factor of 
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101-104 within the same compound between different studies. In one study,  
odour complaints in problem buildings were reported at the sum concentration of 
13 MVOCs of 15 µg/m3, while in the same study odour was not noticed even at 
concentrations up to 40 µg/m3 (197). The authors stated that odour complaints are 
related to the occurrence of individual compounds or their combinations rather 
than the sum of selected MVOCs.  
Despite the lack of studies on concentration-response relationships, MVOCs 
have been associated with general discomfort (i.e. headache, dizziness and 
fatigue) in buildings when occurring in concentrations above the odour thresholds. 
In addition, in epidemiological and case studies, the presence of MVOCs or 
musty, earthy odours has been related to the prevalence of eye, nose, and throat 
irritation, wheezing and other asthma-like symptoms (63, 92, 111, 177, 204, 212). 
Perceived mould odour was found to be a risk indicator for occurrence of nasal 
congestion, excretion, cough, phlegm, wheeze, and the occurrence of symptoms 
was related to the frequency of the days with mould odour expressed (92). In this 
study, the data on symptoms and causes were obtained by questionnaires, and no 
measurements (on e.g. MVOC levels) were performed. In general, when the 
concentration of a non-reactive MVOC exceeds a certain limit, it begins to evoke 
the odour sensation, and if the concentration is high enough, the symptoms of 
irritation appear. Available odour and irritation thresholds for some MVOCs are 
presented in Table 9.  
Some MVOCs, like 3-methylfuran, 2-heptanone, 1-octen-3-ol, and 2-methyl-
isoborneol, were observed to be related to asthma among subjects working in 
schools with elevated levels of airborne fungi (192). The authors point out,  
Table 9. Odour and sensory irritation thresholds/ irritating concentrations for some 
MVOCs most frequently searched for in problem buildings.  
 
Compound Odour 
characterisation 
Odour threshold  
(10, 47, 80, 88, 106, 178, 219) 
Irritation threshold a 
(51) or irritating 
concentration (178)  
 
  ppm mg/m3 ppm mg/m3 
 
2-Methyl-1-propanol Mild, musty, 
fungus-like 
0.001-74 0.003-225 99 300 
3-Methyl-1-butanol Sour, sharp, malty 0.01-35 0.045-126 100 360 
1-Octen-3-ol Raw mushroom - - - - 
2-Hexanone Acetone-like 0.076 0.31   
2-Heptanone Fungus-like, musty 0.02-0.35  0.094-1.6 281 1310 
3-Octanone Mild, fruity, fresh, 
herbal, lavender, 
sweet, fungus-like 
6 31.2 50 260 
2-Methylisoborneol Musty, earthy 0.000001  0.000007  - - 
2-Isopropyl-3-
methoxy-pyrazine 
Musty, mouldy  0.0000002 0.000001 - - 
Geosmin Musty, earthy 0.0009 0.0076 - - 
Dimethyl disulphide Uncomfortable 0.00003-0.09 0.0001-0.3465 - - 
 
a nasal pungency threshold from human anosmics; available for 2-heptanone 
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however, that the occurrence of MVOCs is an indication of active growth of 
microorganisms and not a signal that MVOCs cause asthma. 
There are few studies on MVOCs and irritation/inflammatory responses. In 
human experimental studies by Wålinder et al, some signs of inflammatory 
responses and respiratory reactions were reported after MVOC exposure (see  
also Chapter 11.2). Human subjects (n=30) were exposed to 10 mg/m3 of 1-octen-
3-ol for 2 hours. Increases in eye, nose and throat irritation, headache, dizziness, 
nausea, intoxication, blinking frequency, and in the amounts of lysozyme, myelo-
peroxidase and eosinophilic cationic protein in the nasal lavage fluid were reported 
(232). In another study, 29 healthy volunteers were randomly exposed to sham or 
1 mg/m3 3-methylfuran for 2 hours. No subjective symptom ratings (related to 
smell, irritative and general symptoms) were increased during exposure. However, 
blinking frequency, tear film break-up time, and the lavage biomarkers myelo-
peroxidase and lysozyme were increased and forced vital capacity was decreased 
during exposure to 3-methylfuran compared to ambient air exposure (233). The 
exposure to 3-methylfuran caused an immediate obstructive (during the last 30 
minutes of exposure) and late (three days after exposure) pulmonary reaction in  
a subject with previous occupational fungal exposure and presence of mould 
allergy (234). These experimental exposures were performed with 10 and 500 
times higher concentrations of 1-octen-3-ol and 3-methylfuran, respectively, than 
measured in field samples (Table 5).  
Koren et al reported a two-fold increase in PMNs in nasal lavage of 14 subjects 
immediately after a 4-hour exposure to a mixture of 22 VOCs at a total of 25 
mg/m3 (112), whereas Pappas et al (166) observed no significant increase in 
PMNs in 15 subjects after a for the most part compositionally similar exposure  
of 21 VOCs at 25 mg/m3 and 50 mg/m3. However, increases in lower and upper 
respiratory symptoms were reported both immediately and two hours after 
exposure to VOCs at 50 mg/m3 and increases in upper respiratory symptoms 
immediately after exposure to VOCs at 25 mg/m3. No changes were observed in 
lung function (forced expiratory flow in one second, forced vital capacity, forced 
expiratory flow between 25 and 75 % of forced vital capacity), cellularity or cell 
differentials, biomarkers of airway inflammation including interleukin-8, leuko-
triene B4, or albumin in nasal lavage or induced sputum samples (166). The VOC 
mixtures of Koren et al and Pappas et al, respectively, were designed to mimic the 
levels and types of VOCs found in homes in the United States excluding suspected 
carcinogens and very irritating compounds. However, none of the 15 substances 
evaluated in the present document were included but e.g. p-xylene (8.25 mg/m3), 
1-butanol, ethylbenzene, hexanal, α-pinene (825 µg/m3 each), 2-butanone and 3-
methyl-2-butanone (75 µg/m3 each), which can be regarded as MVOCs.  
In a study by Laumbach et al, 130 healthy women were exposed three times for 
135 minutes each to clean air, or to a mixture of 23 VOCs at 25 mg/m3 with and 
without the addition of 40 ppb ozone. The test mixture was claimed to contain 
some MVOCs but these were not identified nor were their individual concent-
rations specified. Laumbach et al reported no significant differences in nasal 
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irritation symptoms or nasal lavage PMNs between VOC + ozone, VOC alone, or 
clean air conditions, and concluded that MVOCs appear an unlikely cause of acute 
upper respiratory irritation or inflammation (129).  
In a study reported by Claeson (48), 17 women and 10 men were exposed to 
low level emissions from 5 mould species grown on particle board and pine wood 
for 60 minutes. In a second exposure set-up, 13 women and 11 men with or with-
out nose-clip were exposed to moderate level emissions from mouldy building 
materials for 10 minutes. The emissions included 1-butanol, 2-methyl-1-propanol, 
3-methyl-1-butanol, 2-hexanone and 2-heptanone at individual MVOC concent-
rations in the range 0.56-3.4 µg/m3 and 13.2-214 µg/m3 representing low and 
medium (moderate) level exposures, respectively. Exposure to moderate MVOC 
levels in the condition without nose-clip increased the reports of perceived poor 
air quality (stuffy air, smell), and skin irritation. No such outcome was observed 
when participants were exposed to low MVOC levels or to moderate MVOC 
levels with nose-clip. Irrespective of exposure level or duration, no effects on  
the cornea reflected by self-reported tear film break-up time or on attention and 
processing speed were found (48).  
Certain pathophysiological effects, such as the production of inflammatory 
mediators, cell influx into the airways, antibody responses and cell desquamation, 
have been more intensively studied after exposure to other compounds related to 
microbial exposure than the MVOCs. These microbial particulate or non-volatile 
fractions include e.g. fungal and actinomycete spores, cell wall components, 
proteins, glycoproteins, polysaccharides, mycotoxins, and bacterial-derived poly-
peptides and endotoxin. The immune responses may be noticed as the activation 
of PMNs and/or alveolar macrophages resulting in secretion of inflammatory 
mediators like cytokines (9, 156, 173). 
Conclusion 
Microbial VOCs have been related to complaints of general symptoms, as well as 
eye, nose, and throat irritation, and even asthma-like symptoms. However, there is 
a general lack of studies on dose-effect or dose-response relationships regarding 
irritation from single MVOC exposures and from MVOC mixtures. Human irrita-
tion thresholds, determined as nasal pungency thresholds by human anosmics or 
reported irritating concentrations, are available for 4 out of the 15 selected com-
pounds and are considerably higher than measured indoor air levels for these 
compounds. Inflammatory responses have not been definitely confirmed although 
a few experimental studies indicate inflammatory responses and pulmonary 
reactions after exposure to 1-octen-3-ol and 3-methylfuran, respectively, at 
exposure levels 10 and 500 times higher than measured in field. The very few 
experimental studies on exposure to MVOC mixtures and inflammatory effects 
are inconclusive. 
11.2 Effects of single and short-term exposure 
Experimental single exposure studies have been conducted for 5 of the 15 
substances selected for further investigation. In the text below focus is on 
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inhalation and the lowest administered doses. However, if inhalation data  
are lacking or scarce oral data have been included. 
2-Methyl-1-propanol: Human toxicological data are virtually missing. In a 
drinking study in which 10 volunteers were given ethanol in orange juice with or 
without the addition of 2-methyl-1-propanol a clear increase in the frequency of 
errors and subjective hangover symptoms in the post-alcoholic phase was re-
corded with the addition of 2-methyl-1-propanol. No data on ingested amounts 
were given. In another report, it was stated that 2-methyl-propanol vapours cause 
narcosis and irritation of the upper airways. No further details were given (24).  
3-Methyl-1-butanol: Throat irritation was reported in a respiratory uptake study 
in which 4 healthy, male volunteers were exposed through a mouthpiece to 25 
ppm (90 mg/m3) for 10 minutes. In another study, slight throat irritation was 
reported in human volunteers after exposure to 100 ppm (360 mg/m3) 3-methyl-
1-butanol for 3-5 minutes. Following exposure to 150 ppm (540 mg/m3) also eye 
and nose irritation were noted (82).  
1-Octen-3-ol: Mucosal irritation and weak general symptoms were reported  
in human subjects (n=30) exposed to 10 mg/m3 of 1-octen-3-ol for 2 hours. 
Subjective ratings of smell, eye, nose and throat irritation, dizziness, headache, 
intoxication and nausea were increased as were some of the results from objective 
measurements (blinking frequency and levels of the nasal lavage fluid biomarkers 
eosinophilic cationic protein, lysozyme, and myeloperoxidase) (232).  
3-Methylfuran: Twenty-nine healthy volunteers were randomly exposed to 
sham or 1 mg/m3 3-methylfuran for 2 hours. No subjective symptom ratings 
(discomfort in the eyes, nose, and throat, dyspnoea, headache, fatigue, dizziness, 
nausea, and feeling of intoxication) were increased during exposure. However, 
blinking frequency, tear film break-up time, and the lavage biomarkers myelo-
peroxidase and lysozyme were increased and forced vital capacity was decreased 
during exposure to 3-methylfuran compared to sham exposure. In conclusion, the 
acute effects from eyes, nose, and airways indicate mucosal reactive properties  
of 3-methylfuran (233). One subject was removed from the study because of a 
two-phased pulmonary reaction. This suspected adverse reaction was described 
separately in a case-report. The subject suffered an acute obstructive reaction and 
a delayed pulmonary reaction with flu-like symptoms. Previous occupational 
exposure to fungi and presence of mould allergy may have contributed to the 
reaction (234).  
2-Hexanone: Human subjects exposed to 1 000 ppm (4 100 mg/m3) of 2-hexa-
none for a few minutes reported transient moderate eye and nasal irritation (31).  
In a toxicokinetic study where 3 healthy volunteers were exposed to 50 ppm 
(205 mg/m3) of 2-hexanone vapours for 7.5 hours or to 100 ppm (410 mg/m3) for 
4 hours symptoms were not mentioned (31).  
In conclusion, for all of the 15 selected substances data are either totally lacking 
or very scanty. In most of the reported studies doses are high when compared to 
actual MVOC levels in houses. However, acute effects from eyes, nose, and 
airways following exposure to 1 mg/m3 of 3-methylfuran, and 10 mg/m3 of 1-
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octen-3-ol, respectively, have been reported. Still, such exposure levels are 10 and 
500 times higher than levels reported indoors. 
11.3 Effects of long-term exposure 
Relevant long-term studies were found for two of the 15 selected substances,  
all from work environments where the source of exposure was not microbial 
metabolism. 
2-Hexanone: Occupational exposure to 2-hexanone, mostly as a paint thinner 
(usually at least 4 months), has resulted in changes in both motor and sensory 
nerves with symptoms such as muscular weakness and/or trembling of the extre-
mities, and difficulty in walking and handling objects. Also weight reduction has 
been reported in many cases. Medical examination has shown a reduced nerve 
conduction velocity and electromyographic changes. Nerve biopsies have shown 
neurotoxic effects such as axonodal swelling and demyelination. Recovery after 
termination of exposure has been slow and not always complete. In most  
cases nerve function gradually improved but some cases even showed a slight 
worsening. In many cases exposure was both dermal and inhalatory.  
In an epidemiological study, peripheral neuropathy was reported in workers in  
a coated fabrics plant. Four months before the onset of symptoms 2-hexanone had 
been introduced in the solvents in the printing department. Measurements indi-
cated 2-hexanone levels in the range 1-156 ppm (4-640 mg/m3) and on average 
9.2 ppm in front of the printers. However, the air samples were collected after the 
problem had arisen and only 9/17 printing machines were in operation during the 
2-day sampling period. The true exposure levels could therefore not be estimated 
and data were insufficient to correlate 2-hexanone air levels with neurotoxic 
effects. In addition, percutaneous uptake could not be excluded, and also 2-butanone 
(methyl-ethyl ketone) was present in the area (highest measured concentration 
approximately 500 ppm) (31, 32, 138).  
Dimethyl disulphide: Eighty-one pulp mill workers exposed to dimethyl 
disulphide (0-1.5 ppm, 0-5.8 mg/m3), dimethyl sulphide (0-14 ppm), hydrogen 
sulphide (0-6 ppm), and methyl mercaptan (0-15 ppm) complained of inability to 
concentrate, headaches, restlessness, and lack of vigour. However, only the 
increased frequency of headache reached statistical significance compared with 
controls (102).  
The relationship between exposure to organic sulphides and disturbances in iron 
metabolism was investigated in 18 workers at a pulp and paper plant. Measured 
mean exposure levels were low, generally below the detection limits, i.e.<0.2 ppm 
for methylmercaptan, <0.05 ppm for dimethyl sulphide and <0.05 ppm (<0.19 
mg/m3) for dimethyl disulphide. However, peak concentrations of one or two 
orders of magnitude higher were registered. Five subjects experiencing such peaks 
within 2 months before blood sampling had significantly elevated concentrations 
of serum iron and transferrin, and lower ferritin concentrations than referents. As 
an incidental finding, 6 workers not included in the study group involved in the 
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clean up following an explosion had significantly increased serum iron levels at  
2 days compared to 10 days post-exposure (110). 
In conclusion, long-term exposure studies are virtually missing, except for 
2-hexanone, which is an established neurotoxicant. It cannot be excluded that 
peripheral neuropathy may develop in workers exposed to only a few mg/m3 of 
2-hexanone. For comparison, reported levels in non-industrial settings are <9 
µg/m3, i.e. about three orders of magnitude lower. A disturbed iron metabolism 
among workers exposed to organic sulphides has been reported. Levels of 
dimethyl disulphide were several orders of magnitude above those reported in 
indoor air. 
11.4 Genotoxic effects 
No studies on genotoxic effects in humans were found for the 15 substances 
selected for further investigation. 
11.5 Carcinogenic effects 
No studies assessing the carcinogenic potential in humans were found following 
exposure to any of the 15 substances selected for further investigation. 
11.6 Reproductive and developmental effects 
No studies on reproductive and developmental effects in humans were found for 
the 15 substances selected for further investigation.  
12. Dose-effect and dose-response relationships 
Data on exposure levels and toxicological effects presented earlier in the 
document are summarised below. Data are given for both MVOC mixtures and  
15 individual substances representing the MVOCs most often analysed and 
reported in previous MVOC studies.  
12.1 Animal data 
Sensory irritation potency has been assessed for several MVOCs by determining 
the concentration causing a 50 % decrease in respiratory rate in mice (RD50) (see 
also 12.3). At low exposure levels to MVOC mixtures it has been assumed that 
sensory irritation effects are additive. If so, the total sensory potency of a specific 
MVOC mixture can be calculated. However, at higher exposure concentrations 
MVOCs may have synergistic effects on sensory irritation (156). It has been 
shown that the determined RD50 for an MVOC mixture was lower than estimated 
from the sum of fractional concentrations and the RD50s of individual compounds 
(114). 
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Irritation effects of short-term, repeated exposure (30 minutes/day for 4 days) to 
3-octanone, 1-octen-3-ol or to a mixture of 2-methyl-1-propanol, 3-methyl-1-buta-
nol, 1-octen-3-ol, 2-heptanone and 3-octanone by the mouse bioassay at levels 
ranging from <0.001 to 0.2·RD50 seemed non-cumulative and transient (115). 
Levels were chosen to produce a clear respiratory rate decrease, and proportions 
of the MVOCs in the mixture to reflect those measured in mouldy buildings or 
mouldy building materials.  
Based on acute toxicity studies on the 15 selected substances the alcohols, 
ketones and 3-methylfuran would be classified as slightly toxic. The database is, 
however, poor for most of the compounds. Virtually no data exist for 2-octen-1-ol, 
2-pentanol, 3-octanone, geosmin, 2-methylisoborneol and 2-isopropyl-3-methoxy-
pyrazine.  
2-Hexanone is a well-established neurotoxicant. Neurotoxic effects, expressed 
as peripheral neuropathy, and weight loss/retarded weight gain have been observed 
in several species after repeated exposures and different modes of administration. 
The lowest inhalation exposure level reported to produce adverse effects in animals 
is 50 ppm (205 mg/m3). Although no effects were observed at an exposure of 40 
ppm (164 mg/m3) for up to 88 days, it cannot be ruled out that signs of neuropathy 
may have developed later. The neurotoxicity of 2-hexanone is enhanced by co-
exposure to other chemicals e.g. 2-butanone (methyl ethyl ketone), and 2-hexanone 
can also potentiate the toxicity of other compounds (31, 32, 138). Reported indoor 
air levels of 2-hexanone as an MVOC are <9 µg/m3.  
Regarding dimethyl disulphide, two inhalation studies of rats exposed 6 hours/ 
day, 5 days/week for 13 weeks have been performed according to current stan-
dards. Both studies indicate a NOEL below 10 ppm (38 mg/m3) (13, 108). The 
highest reported concentrations of dimethyl disulphide in buildings are approxi-
mately 0.1 µg/m3. 
Moreover, the few available repeated exposure studies on 3-methyl-1-butanol, 
2-methyl-1-propanol, 3-octanol and 2-heptanone suggest NOELs at least three 
orders of magnitude higher than the reported concentrations in problem or 
complaint buildings.  
12.2 Human data  
Reported concentrations of single MVOCs in buildings with indoor air problems 
(microbial growth, odour complaints) range from a few ng/m3 to <1 mg/m3. 
However, comparisons between studies are hampered by a lack of standardised 
and validated analytical methods for MVOCs. There is a considerable overlap of 
the results for both single and sums of several MVOCs in contaminated areas, 
clean areas and outdoor air. 
There is a general lack of studies on dose-effect or dose-response relationships 
regarding irritation and other effects from exposure to individual MVOCs and 
MVOC mixtures. In epidemiological and case studies, MVOCs or musty, earthy 
odours have been related to complaints of general symptoms (i.e. headache, 
dizziness and fatigue) as well as eye, nose, and throat irritation, and even asthma-
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like symptoms (63, 92, 111, 177, 204, 212). It has been suggested that odour 
complaints may be related to the occurrence of individual compounds or their 
combinations rather than the sum of selected MVOCs (92). However, if MVOCs 
are present in the air, other agents, e.g. fungal components will presumably be 
present as well. 
Fifteen substances most often determined as MVOCs in field samplings were 
selected for further examination (Table 2). Available odour and irritation thres-
holds for those MVOCs are presented in Table 9. Odour thresholds may differ 
considerably both between substances and between studies of the same com-
pound. Irritation thresholds/irritating concentrations are in the range 50-280 ppm, 
but are available only for 4 of the 15 selected compounds.  
Inflammatory responses of single or repeated MVOC exposures have not been 
unequivocally confirmed in human experimental studies. The very few studies  
on MVOC mixtures are inconclusive. An increase in PMNs in nasal lavage were 
reported in a study on 14 subjects exposed to 22 VOCs at 25 mg/m3 (112) whereas 
no such change was fond in two other studies on MVOC mixtures (129, 166). 
However, signs of inflammatory responses, and respiratory reactions were repor-
ted after single exposures to 1-octen-3-ol (10 mg/m3) (232), and 3-methylfuran  
(1 mg/m3) (233, 234), respectively. The experimental exposure levels in these 
studies were approximately 10 and 500 times higher than levels measured in field.  
Dose-effect relationships after single and short-term exposure to VOCs, single 
or in combinations, are presented in Table 10. In general, the toxicological data on 
these compounds are poor. Virtually no data exist for 2-octen-1-ol, 2-pentanol, 
3-octanone, geosmin, 2-methylisoborneol and 2-isopropyl-3-methoxy-pyrazine.  
In an epidemiological study, peripheral neuropathy was reported in workers 
exposed to 2-hexanone. Measurements performed after the onset of problems 
indicated levels in the range 1-156 ppm (4-640 mg/m3) and also 2-butanone was 
present. Respiratory and percutaneous uptake could not be separated and precise 
exposure levels were not known, (31, 32, 138). It can therefore not be ruled out 
that severe neuropathy has developed at exposure concentrations down to one or a 
few ppm. Such 2-hexanone levels would still be more than 400 times higher than 
those encountered in indoor air. 
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12.3 Extrapolation of animal data on sensory irritation responses to humans 
At the levels relevant in this context, the effects from MVOC exposure are those 
related to irritation in the eyes and upper airways. At higher exposure levels 
MVOCs may cause also other effects. Thus, the evaluation of human health risks 
caused by MVOC exposure focuses on the sensory irritation. Sensory irritation 
potency is assessed by determining the RD50 in mice (Chapter 10.1). However,  
the question of the application of RD50s to human responses is a critical issue. 
Cometto-Muñiz and Cain showed that the sensory irritation potencies of 21 VOCs 
(consisting of e.g. alcohols, acetates, ketones, alkylbenzenes) estimated in the 
mouse bioassay were well correlated (r = 0.85) with the human potencies, mea-
sured as the nasal pungency thresholds (51). The extrapolation of the mouse 
bioassay to human exposures predicted that, in general, slight but tolerable 
irritation would occur at 0.1·RD50 and minimal or no effect at 0.01·RD50 (101). 
Further, regression analyses suggest that RD50s correlate with the threshold limit 
values (TLVs) elaborated by American Conference of Governmental Industrial 
Hygienists (ACGIH) (r = 0.88) with a slope factor (regression coefficient) of 0.03 
(the mid-point between 0.1 and 0.01 on a logarithmic scale) (180). As a pragmatic 
approach, such levels (0.03·RD50) could constitute an acceptable level of human 
exposure to prevent sensory irritation in work environments. The RD50s and 
corresponding 0.03·RD50s for the selected MVOCs are presented in Table 11.  
For the tabulated MVOCs the 0.03·RD50s are in the range 5-530 mg/m3 (approx-
imately 0.9-100 ppm).  
The levels of the compounds usually measured in water damaged and/or mould 
problem buildings (Table 5), are generally several orders of magnitude lower than 
the 0.03·RD50s given in Table 11. For such low-concentration mixtures of MVOCs, 
it seems prudent to apply the additivity rule (7). The underlying assumption is that 
all the compounds act on the same biological site and individual compounds act as  
 
Table 11. The RD50s (114, 168, 180) and 0.03·RD50s for some MVOCs. The values for 
acrolein and formaldehyde were added for comparison. 
 
Compound RD50 (mg/m3) 0.03.RD50 (mg/m3) 
 
2-Methyl-1-propanol 5 499 165 
3-Methyl-1-butanol 9 325 280 
3-Methyl-2-butanol 9 645 289 
2-Pentanol 9 907 297 
3-Octanol 1 359 41 
1-Octen-3-ol 182 5.5 
2-Hexanone 10 449 313a 
2-Heptanone 4 163 125 
3-Octanone 17 586 528 
2-Methylisoborneol 811 24 
Geosmin 216 6.5 
Acrolein 4 0.12 
Formaldehyde 5 0.15 
 
a Neurotoxicity appears at lower exposure levels (Chapters 10.3 and 11.3). 
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dilutions (depending on their relative potencies) of the same toxic compound 
(122). For the occupational setting the additive effect could be calculated as 
follows:  
 
 Additive effect = ∑ (cn / 0.03·RD50n), where 
 
c= measured concentration of a chemical 
 
If the additive effect exceeds the value 1, sensory irritation may be expected, 
whereas levels below 1 should be of no concern (7).  
The interest in the indoor environment is to protect the general, rather than the 
working, population. This includes sensitive individuals (e.g. asthmatics and 
children) and continuous exposure for 24 hours per day. On this basis, Nielsen  
et al proposed that the 0.03·RD50 should be divided by 40 when calculating a 
recommended indoor air level (RIL) for individual non-reactive VOCs outside the 
occupational settings. The factor 40 includes a four times longer duration of 
indoor air exposure compared to occupational exposure and a safety factor of 10 
for potential risk groups (156). The assumption of additivity and, thus the same 
procedure for calculating the additive effect, applies also for RILs. 
However, it should be pointed out that the approach to calculate “acceptable” 
levels is applicable only for sensory irritation effects. For reactive substances or 
substances with effects other than sensory irritation as the primary concern, other 
extrapolations to protect humans should be applied.  
Pasanen et al calculated RILs for 27 MVOCs in a theoretical setting and for  
3-14 MVOCs with reported concentrations in some problem buildings. Individual 
RILs for single MVOCs approach hundreds (e.g. 1-octen-3-ol, 2-methylisoborneol, 
geosmin) or thousands of µg/m3 (e.g. 2-methyl-1-butanol, 3-methyl-1-butanol,  
3-methyl-2-butanol, 2-pentanol, 3-octanol, 2-hexanone, 2-heptanone) (168). Such 
high MVOC concentrations rarely occur in regular indoor environments.  
Laumbach et al and Sigsgaard and Bornehag have recently reached the same 
conclusion (129, 189). Similarly, Böck concluded, based on literature data, that  
the indoor concentrations of single MVOCs are 4-6 orders below their RD50s (35). 
Both in theoretical calculations and based on MVOC concentrations measured 
in some problem buildings, when assuming additivity the total effect has remained 
below unity even when using RILs instead of 0.03·RD50s as acceptable limits (see 
the above mentioned formula), indicating that irritation symptoms due to MVOCs 
should not be expected. These authors also estimated that microbial growth seems 
to have only marginal effects on the total VOC load in the room (168). Odour 
thresholds, indoor air concentrations, and the 0.03·RD50s are combined and 
presented in Figure 2. 
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Figure 2. The 0.03·RD50s (•), odour thresholds as ranges or single values (grey lines) and 
indoor air concentrations (black lines) of selected MVOCs, when available. The indoor 
air concentrations have been measured in residences or in non-industrial work sites such 
as schools.  
13. Previous evaluations by national and international bodies  
No evaluation related to health risks of MVOCs in general was found in the 
literature. Considering the 15 selected compounds, health risks have been 
evaluated for five of them, as presented in Table 12. However, it should be  
noted that the purpose of these evaluations has been to estimate the health risks  
in industrial work environments and processes where workers are exposed to 
much higher concentrations of one or a few of these chemicals. This contrasts 
with exposure to chemicals of microbial origin (e.g. in buildings with moisture 
and microbial damage) where people are exposed to a wide range of MVOCs 
albeit at much lower concentrations. 
mg/m3 
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14. Evaluation of human health risks  
14.1 Assessment of health risks 
It is difficult to evaluate human health risks because of the lack of sufficient 
knowledge of the specific MVOCs, exposure to MVOCs (in particular mixtures) 
especially in work environments, and of the mechanism of possible health effects 
of MVOCs. Furthermore, if there are MVOCs in the air there will most certainly 
be other agents, e.g. fungal components, present as well. The toxicological data-
base is poor, at least for the 15 typically analysed MVOCs. Considering typical 
MVOCs - as reported qualitatively and quantitatively in the field so far - it 
appears evident that eye and upper respiratory tract (sensory) irritation is the most 
probable response to MVOC exposure, and no long-term or more toxic effects  
are expected. Inflammatory responses (e.g. increase in the count of inflammatory 
cells or other mediators) after single or repeated MVOC exposures have not been 
unequivocally confirmed in controlled human exposure studies. Thus, sensory 
irritation by the stimulation of the trigeminal nerves seems to be the most likely 
mechanism of toxicity of typical MVOCs. Occupational exposure limits (OELs) 
based on irritation as the critical effect have been shown to correlate roughly to 
3 % of their respective RD50s. This would correspond to 5-530 mg/m3 (0.9-100 
ppm) for the 15 typical MVOCs, with geosmin and 1-octen-3-ol in the lower, and 
3-octanone in the higher range. A further reduction by a factor of 40 has been 
proposed to protect the general population, including sensitive groups, which 
would correspond to 0.1-13 mg/m3 for the individual MVOCs evaluated in this 
document. 
14.2 Groups at extra risk 
In the light of present knowledge, no long-term health effects are expected as a 
result of exposure to concentrations of MVOCs measured in buildings with 
moisture and microbial damage. There are no scientific data available suggesting 
that any particular group is at extra risk. 
14.3 Scientific basis for an occupational exposure limit 
There are insufficient data to serve as basis to establish OELs for MVOC 
mixtures. There is no clear definition, but several hundred substances may be 
considered as MVOCs. With a few exceptions, little is known about the concent-
rations of these substances in indoor air and even less is known about their health 
hazards. Measurements in indoor air have generally focused on a relatively small 
number of substances. 
It should be pointed out, however, that some of the substances considered as 
MVOCs are also used in industry and/or occur at relatively high levels in the work 
environment. For these substances more is known about exposure levels in work 
places and health effects and some have established OELs.  
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Sensory irritation seems to be the critical effect for many of the individual 
substances. Considering the low levels generally occurring in indoor air, it seems 
prudent to apply the additivity rule to calculate the risk for sensory irritation. Such 
calculations based on the RD50s determined in mice suggest that the MVOC 
concentrations measured so far in indoor environments are well below the levels 
expected to cause sensory irritation. However, such exercises must be executed 
and interpreted with care and cannot be applied to reactive substances, and 
substances with other endpoints than irritation as the major concern (2-hexanone). 
15. Research needs  
In the past, MVOCs have been a focus of research in two ways: as indicators of 
microbial growth in a substrate (foodstuffs, building constructions) or as possible 
causative agents for adverse health effects in buildings with moisture and micro-
bial damage. However, among the compounds identified so far, none has been 
verified as a “pure”, MVOC, i.e. of solely microbial origin. Possible candidate 
groups for such specific MVOCs could include sesquiterpenes, furans, and very 
volatile compounds. The search requires further development of analytical 
methods. The other approach to increase the reliable interpretation of MVOC 
results might be to focus on statistical data handling of chromatograms. Some 
attempts on application of the principal component analyses have been made, but 
this area needs more research. On the other hand, statistical analyses require large 
databases on MVOC concentrations (exposure data) in different environments  
and occasions collected with the identical methodology. Before databases can be 
gathered, consensus on recommended sampling and analytical methods should be 
reached among researchers. These measures are necessary, if MVOC analysis is 
intended to be utilised further either in the research or in field settings, although 
according to the present knowledge, the use of MVOC concentrations for both the 
above mentioned purposes appears to be questionable.  
Considering health effects of MVOCs, more in vitro and in vivo data on the 
inflammatory and other immunological responses to MVOCs are needed. Further-
more, information on co-effects of several microbiological agents is still missing, 
though it is evident that no single agent studied so far is responsible for the health 
effects observed in subjects exposed to microorganisms in living and work 
environments. One possibility is to direct the measurements towards more reactive 
compounds (such as amines, acids), as they are more likely to affect human 
health. 
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16. Summary  
Pasanen A-L, Järnberg J, Korpi A. The Nordic Expert Group for Criteria 
Documentation of Health Risks from Chemicals. 138. Microbial volatile organic 
compounds (MVOCs). Arbete och Hälsa 2006;13:1-78. 
 
Microbial volatile organic compounds (MVOCs) consist of a variety of com-
pounds (mainly alcohols, ketones, terpenes, esters, aldehydes, sulphur and 
nitrogen compounds) formed as side-products in the primary and secondary 
metabolism of fungi and bacteria. More than 200 compounds have been identified 
as MVOCs in laboratory experiments, but none can be regarded as exclusively of 
microbial origin or specific for certain microbial species. Thus, these compounds 
also have many other, often much stronger, sources than microbial metabolism in 
the environment. Furthermore, the techniques chosen for sampling and analysis 
will effect which MVOCs are detected. In many cases, the typcially 10-15 com-
pounds analysed have been selected beforehand based on previous investigations 
as well as existing analytical facilities.  
In this review, the basic physical and chemical properties of 96 typical MVOCs 
have been summarised. Of these, the 15 MVOCs listed below have most often 
been analysed and reported in buildings with moisture and microbial damage and 
sometimes in occupational settings (in agriculture or compost facilities). These 
were also the MVOCs for which the toxicological and exposure data were 
gathered in this report: 
 
2-Methyl-1-propanol 1-Octen-3-ol 3-Octanone 
3-Methyl-1-butanol  2-Octen-1-ol 2-Methylisoborneol 
3-Methyl-2-butanol 3-Methylfuran 2-Isopropyl-3-methoxy-pyrazine 
2-Pentanol 2-Hexanone Geosmin 
3-Octanol  2-Heptanone Dimethyl disulphide 
 
In studies with quantitative MVOC results, single MVOC levels have ranged 
from a few ng/m3 up to 1 mg/m3 both in indoor and work environments, however, 
quantitative data from work settings are limited to compost facilities. The compa-
rable data on MVOC levels in the environment published so far are inadequate for 
drawing reliable conclusions on the MVOC exposure.  
The main exposure route for MVOCs is absorption through the lungs. Typical 
MVOCs are rapidly metabolised and excreted in the urine and bile. Generally, 
MVOCs do not accumulate in tissues to any great extent.  
The toxicological database is poor for the 15 listed MVOCs. In epidemiological 
studies on buildings with moisture and microbial damage, MVOCs, in addition to 
many other microbial agents, have been associated with unpleasant odours, eye 
and upper airway irritation, unspecific symptoms and even asthma-like symptoms. 
However, inflammatory responses of single or repeated MVOC exposures have 
not been unequivocally confirmed in controlled human exposure studies. The 
most obvious health effect of MVOC exposure is eye and upper airway irritation, 
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due to stimulation of the trigeminal nerves (sensory irritation), which seems to be 
the critical effect also for many individual MVOCs although there are exceptions 
(2-hexanone). In human experimental exposure studies, symptoms of irritation 
have appeared at MVOC concentrations several orders of magnitude higher than 
those measured under field conditions in indoor environments. This is supported 
by data from animal studies. According to the database determined by the ASTM 
mouse bioassay, dose-dependent sensory irritation has been detected for many 
typical MVOCs. Assuming additivity of the sensory irritation reaction, the irrita-
tion responses anticipated from exposure to MVOC mixtures lead to the conclusion 
that MVOCs - as combinations and concentrations reported so far - are well below 
the levels needed to cause sensory irritation.  
Overall, considering the very low levels encountered in the MVOC context, no 
toxic effects besides irritation, and very seldom also this effect, are expected. On 
the other hand, the present document covers the toxicological data of only 15 out 
of more than 200 MVOCs recognised so far. Thus, the conclusions do not neces-
sarily apply to all MVOCs, and not even for all of the 15 compounds evaluated, as 
there may be more potent compounds and/or other endpoints not yet evaluated. 
So far, attempts to recognise microbially contaminated buildings or areas, or to 
verify the success of remedial measures by MVOC measurements have failed 
because of considerable overlap of the results (both for individual MVOCs and 
sums of several MVOCs) between suspected and control areas. Thus, in order to 
identify contaminated buildings by MVOC measurements, MVOCs of purely 
microbial origin and/or sophisticated data handling procedures are needed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: health effect, microbial volatile organic compound, MVOC, 
occupational exposure limit, respiratory effects, review, risk assessment, sensory 
irritation, toxicity 
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17. Summary in Swedish  
Pasanen A-L, Järnberg J, Korpi A. The Nordic Expert Group for Criteria 
Documentation of Health Risks from Chemicals. 138. Microbial volatile organic 
compounds (MVOCs). Arbete och Hälsa 2006;13:1-78. 
 
Mikrobiella flyktiga organiska ämnen (MVOC) består av en mängd olika ämnen 
(huvudsakligen alkoholer, ketoner, terpener, estrar, aldehyder, svavel- och kväve-
föreningar) som bildas som biprodukter vid svampars och bakteriers primära och 
sekundära metabolism. Över 200 ämnen har identifierats som MVOC vid labora-
torieförsök, men inga av dessa kan anses ha enbart mikrobiellt ursprung eller vara 
specifika för en speciell mikroorganism eftersom MVOC har andra, ofta mycket 
mer betydelsefulla källor i miljön. Även provtagnings- och analysmetodiken har 
betydelse för vilka ämnen som detekteras. I många fall har antalet ämnen som 
analyseras begränsats till 10-15 st vilka valts på förhand utifrån tidigare laboratorie- 
eller fältförsök och på tillgänglig analysutrustning.  
I det här kriteriedokumentet sammanfattades fysikaliska och kemiska egen-
skaper för 96 typiska MVOC. Av dessa har följande 15 ämnen oftast analyserats 
och rapporterats förekomma i byggnader med fukt- och mikrobiella skador samt 
ibland i arbetsmiljöer (inom jordbruk och kompostering). För dessa ämnen ges 
exponeringsdata och en toxikologisk översikt.  
 
2-Metyl-1-propanol 2-Okten-1-ol 3-Oktanon 
3-Metyl-1-butanol  3-Oktanol 2-Metylisoborneol 
3-Metyl-2-butanol 3-Metylfuran 2-Isopropyl-3-metoxi-pyrazin 
2-Pentanol 2-Hexanon Geosmin 
1-Okten-3-ol 2-Heptanon Dimetyldisulfide 
 
I studier med kvantitativa uppgifter om MVOC har nivåerna av enskilda ämnen 
varierat mellan några få ng/m3 upp till 1 mg/m3 både inomhus och i arbetsmiljöer, 
även om kvantitativa data från arbetsplatser är sällsynta. Hittills publicerade och 
jämförbara data på MVOC-nivåer i miljön är för bristfälliga för att man ska kunna 
dra några långtgående slutsatser om MVOC-exponering.  
Upptag via lungorna är den huvudsakliga exponeringsvägen för MVOC. 
Typiska MVOC metaboliseras snabbt och utsöndras i urinen och gallan. Generellt 
ackumuleras inte MVOC i vävnader och organ i någon större utsträckning. 
Den toxikologiska databasen är mager för de 15 listade MVOC. I epidemiolo-
giska studier av byggnader med fukt- och mikrobiella skador har obehaglig lukt, 
ögon- och övre luftvägsirritation samt ospecifika och till och med astmaliknande 
symtom satts i samband med MVOC och även många andra mikrobiologiska 
agens. Det har emellertid inte otvetydigt påvisats något inflammatoriskt svar efter 
enstaka eller upprepade MVOC-exponeringar i kontrollerade humanstudier. Den 
mest uppenbara effekten av exponering för MVOC är ögon- och övre luftvägs-
irritation via stimulering av trigeminalnerven (sensorisk irritation), vilket tycks 
vara den kritiska effekten även för många enskilda MVOC även om det finns 
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undantag (2-hexanon). I exponeringsstudier på människa har irritationssymtom 
uppkommit vid MVOC-nivåer som är flera tiopotenser högre än de man mätt i 
inomhusmiljöer. Detta stöds av data från djurstudier. Enligt den databas som 
bygger på resultat från en djurmodell (ASTM mouse bioassay) har dosberoende 
sensorisk irritation detekterats för många typiska MVOC. Förutsatt att additivitet 
gäller för sensorisk irritation av MVOC blir dock slutsatsen att de kombinationer 
och koncentrationer av MVOC som hittills rapporterats inte ger upphov till denna 
effekt.  
Med tanke på de mycket låga nivåer som förekommer i MVOC-sammanhang 
förväntas inga andra toxiska effekter förutom irritation och således mycket sällan 
också det. Detta dokument täcker emellertid toxikologiska data för endast 15 av 
mer än 200 ämnen som anses vara MVOC. Slutsatserna gäller således inte nöd-
vändigtvis alla MVOC, och kanske inte ens de 15 som utvärderats, eftersom det 
kan finnas mer potenta ämnen och/eller andra effekter som ännu inte utvärderats.  
Ansträngningar att identifiera mikrobiologiskt kontaminerade byggnader eller 
områden, eller att verifiera effekten av åtgärder genom MVOC-mätningar, har 
hittills misslyckats på grund av betydande överlappning mellan misstänkta 
områden och kontrollområden, både vad gäller nivåer av enskilda MVOC och 
summan av flera MVOC. För att skadade byggnader ska kunna identifieras med 
hjälp av MVOC-mätningar behövs MVOC med enbart mikrobiellt ursprung 
och/eller avancerade databehandlingsmetoder. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nyckelord: hygieniskt gränsvärde, hälsoeffekter, mikrobiella flyktiga organiska 
ämnen, MVOC, respiratoriska effekter, riskbedömning, sensorisk irritation, 
toxicitet, översikt 
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19. Data bases used in search of literature  
In the search for literature the following databases were used: 
 
CAB Abstracts 
CAS registry file (STN)  
HSELINE 
IARC cancer databases 
ISI Web of science 
NIOSHTIC 
PubMed 
RISKLINE 
RTECS 
Toxnet databases (including e.g. HSDB, Toxline, CCRIS, and Genetox) 
 
In addition, literature cited in the thesis of Anne Korpi (113) was used. Major 
searches were performed during March-April 2005 for MVOCs and December 
2005-June 2006 for single substances. A final search in PubMed and ISI on 
MVOCs (no single substances) was performed 28 November, 2006. 
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